Skip to main content

This is a preview of improvements coming to the PMC website in October 2024. Learn more

Return to current site
PMC home page
Logo of Biochemical Journal Link to view articles on publisher site
. 1998 Aug 1;333(Pt 3):471–490. doi: 10.1042/bj3330471

Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling.

P R Shepherd 1, D J Withers 1, K Siddle 1
PMCID: PMC1219607  PMID: 9677303

Abstract

Insulin plays a key role in regulating a wide range of cellular processes. However, until recently little was known about the signalling pathways that are involved in linking the insulin receptor with downstream responses. It is now apparent that the activation of class 1a phosphoinositide 3-kinase (PI 3-kinase) is necessary and in some cases sufficient to elicit many of insulin's effects on glucose and lipid metabolism. The lipid products of PI 3-kinase act as both membrane anchors and allosteric regulators, serving to localize and activate downstream enzymes and their protein substrates. One of the major ways these lipid products of PI 3-kinase act in insulin signalling is by binding to pleckstrin homology (PH) domains of phosphoinositide-dependent protein kinase (PDK) and protein kinase B (PKB) and in the process regulating the phosphorylation of PKB by PDK. Using mechanisms such as this, PI 3-kinase is able to act as a molecular switch to regulate the activity of serine/threonine-specific kinase cascades important in mediating insulin's effects on endpoint responses.

Full Text

The Full Text of this article is available as a PDF (508.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akimoto K., Takahashi R., Moriya S., Nishioka N., Takayanagi J., Kimura K., Fukui Y., Osada S. i., Mizuno K., Hirai S. i. EGF or PDGF receptors activate atypical PKClambda through phosphatidylinositol 3-kinase. EMBO J. 1996 Feb 15;15(4):788–798. [PMC free article] [PubMed] [Google Scholar]
  2. Aledo J. C., Darakhshan F., Hundal H. S. Rab4, but not the transferrin receptor, is colocalized with GLUT4 in an insulin-sensitive intracellular compartment in rat skeletal muscle. Biochem Biophys Res Commun. 1995 Oct 4;215(1):321–328. doi: 10.1006/bbrc.1995.2469. [DOI] [PubMed] [Google Scholar]
  3. Alessi D. R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B. A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996 Dec 2;15(23):6541–6551. [PMC free article] [PubMed] [Google Scholar]
  4. Alessi D. R., Caudwell F. B., Andjelkovic M., Hemmings B. A., Cohen P. Molecular basis for the substrate specificity of protein kinase B; comparison with MAPKAP kinase-1 and p70 S6 kinase. FEBS Lett. 1996 Dec 16;399(3):333–338. doi: 10.1016/s0014-5793(96)01370-1. [DOI] [PubMed] [Google Scholar]
  5. Alessi D. R., Deak M., Casamayor A., Caudwell F. B., Morrice N., Norman D. G., Gaffney P., Reese C. B., MacDougall C. N., Harbison D. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase. Curr Biol. 1997 Oct 1;7(10):776–789. doi: 10.1016/s0960-9822(06)00336-8. [DOI] [PubMed] [Google Scholar]
  6. Alessi D. R., James S. R., Downes C. P., Holmes A. B., Gaffney P. R., Reese C. B., Cohen P. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol. 1997 Apr 1;7(4):261–269. doi: 10.1016/s0960-9822(06)00122-9. [DOI] [PubMed] [Google Scholar]
  7. Alessi D. R., Kozlowski M. T., Weng Q. P., Morrice N., Avruch J. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr Biol. 1998 Jan 15;8(2):69–81. doi: 10.1016/s0960-9822(98)70037-5. [DOI] [PubMed] [Google Scholar]
  8. Altschuler D., Yamamoto K., Lapetina E. G. Insulin-like growth factor-1-mediated association of p85 phosphatidylinositol 3-kinase with pp 185: requirement of SH2 domains for in vivo interaction. Mol Endocrinol. 1994 Sep;8(9):1139–1146. doi: 10.1210/mend.8.9.7838146. [DOI] [PubMed] [Google Scholar]
  9. Anai M., Funaki M., Ogihara T., Terasaki J., Inukai K., Katagiri H., Fukushima Y., Yazaki Y., Kikuchi M., Oka Y. Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats. Diabetes. 1998 Jan;47(1):13–23. doi: 10.2337/diab.47.1.13. [DOI] [PubMed] [Google Scholar]
  10. Andjelković M., Alessi D. R., Meier R., Fernandez A., Lamb N. J., Frech M., Cron P., Cohen P., Lucocq J. M., Hemmings B. A. Role of translocation in the activation and function of protein kinase B. J Biol Chem. 1997 Dec 12;272(50):31515–31524. doi: 10.1074/jbc.272.50.31515. [DOI] [PubMed] [Google Scholar]
  11. Andreotti A. H., Bunnell S. C., Feng S., Berg L. J., Schreiber S. L. Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature. 1997 Jan 2;385(6611):93–97. doi: 10.1038/385093a0. [DOI] [PubMed] [Google Scholar]
  12. Antonetti D. A., Algenstaedt P., Kahn C. R. Insulin receptor substrate 1 binds two novel splice variants of the regulatory subunit of phosphatidylinositol 3-kinase in muscle and brain. Mol Cell Biol. 1996 May;16(5):2195–2203. doi: 10.1128/mcb.16.5.2195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Araki E., Lipes M. A., Patti M. E., Brüning J. C., Haag B., 3rd, Johnson R. S., Kahn C. R. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature. 1994 Nov 10;372(6502):186–190. doi: 10.1038/372186a0. [DOI] [PubMed] [Google Scholar]
  14. Arcaro A., Wymann M. P. Wortmannin is a potent phosphatidylinositol 3-kinase inhibitor: the role of phosphatidylinositol 3,4,5-trisphosphate in neutrophil responses. Biochem J. 1993 Dec 1;296(Pt 2):297–301. doi: 10.1042/bj2960297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Argetsinger L. S., Hsu G. W., Myers M. G., Jr, Billestrup N., White M. F., Carter-Su C. Growth hormone, interferon-gamma, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J Biol Chem. 1995 Jun 16;270(24):14685–14692. doi: 10.1074/jbc.270.24.14685. [DOI] [PubMed] [Google Scholar]
  16. Aroca P., Mahadevan D., Santos E. Functional interactions between isolated SH2 domains and insulin/Ras signaling pathways of Xenopus oocytes: opposite effects of the carboxy- and amino-terminal SH2 domains of p85 PI 3-kinase. Oncogene. 1996 Nov 7;13(9):1839–1846. [PubMed] [Google Scholar]
  17. Azpiazu I., Saltiel A. R., DePaoli-Roach A. A., Lawrence J. C. Regulation of both glycogen synthase and PHAS-I by insulin in rat skeletal muscle involves mitogen-activated protein kinase-independent and rapamycin-sensitive pathways. J Biol Chem. 1996 Mar 1;271(9):5033–5039. doi: 10.1074/jbc.271.9.5033. [DOI] [PubMed] [Google Scholar]
  18. Backer J. M., Myers M. G., Jr, Shoelson S. E., Chin D. J., Sun X. J., Miralpeix M., Hu P., Margolis B., Skolnik E. Y., Schlessinger J. Phosphatidylinositol 3'-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J. 1992 Sep;11(9):3469–3479. doi: 10.1002/j.1460-2075.1992.tb05426.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Backer J. M., Myers M. G., Jr, Sun X. J., Chin D. J., Shoelson S. E., Miralpeix M., White M. F. Association of IRS-1 with the insulin receptor and the phosphatidylinositol 3'-kinase. Formation of binary and ternary signaling complexes in intact cells. J Biol Chem. 1993 Apr 15;268(11):8204–8212. [PubMed] [Google Scholar]
  20. Baltensperger K., Kozma L. M., Jaspers S. R., Czech M. P. Regulation by insulin of phosphatidylinositol 3'-kinase bound to alpha- and beta-isoforms of p85 regulatory subunit. J Biol Chem. 1994 Nov 18;269(46):28937–28946. [PubMed] [Google Scholar]
  21. Bandyopadhyay G., Standaert M. L., Galloway L., Moscat J., Farese R. V. Evidence for involvement of protein kinase C (PKC)-zeta and noninvolvement of diacylglycerol-sensitive PKCs in insulin-stimulated glucose transport in L6 myotubes. Endocrinology. 1997 Nov;138(11):4721–4731. doi: 10.1210/endo.138.11.5473. [DOI] [PubMed] [Google Scholar]
  22. Barylko B., Binns D., Lin K. M., Atkinson M. A., Jameson D. M., Yin H. L., Albanesi J. P. Synergistic activation of dynamin GTPase by Grb2 and phosphoinositides. J Biol Chem. 1998 Feb 6;273(6):3791–3797. doi: 10.1074/jbc.273.6.3791. [DOI] [PubMed] [Google Scholar]
  23. Batty I. H., Downes C. P. Thrombin receptors modulate insulin-stimulated phosphatidylinositol 3,4,5-trisphosphate accumulation in 1321N1 astrocytoma cells. Biochem J. 1996 Jul 15;317(Pt 2):347–351. doi: 10.1042/bj3170347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Begum N., Ragolia L. cAMP counter-regulates insulin-mediated protein phosphatase-2A inactivation in rat skeletal muscle cells. J Biol Chem. 1996 Dec 6;271(49):31166–31171. doi: 10.1074/jbc.271.49.31166. [DOI] [PubMed] [Google Scholar]
  25. Benjamin W. B., Pentyala S. N., Woodgett J. R., Hod Y., Marshak D. ATP citrate-lyase and glycogen synthase kinase-3 beta in 3T3-L1 cells during differentiation into adipocytes. Biochem J. 1994 Jun 1;300(Pt 2):477–482. doi: 10.1042/bj3000477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Björnholm M., Kawano Y., Lehtihet M., Zierath J. R. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes. 1997 Mar;46(3):524–527. doi: 10.2337/diab.46.3.524. [DOI] [PubMed] [Google Scholar]
  27. Bokoch G. M., Vlahos C. J., Wang Y., Knaus U. G., Traynor-Kaplan A. E. Rac GTPase interacts specifically with phosphatidylinositol 3-kinase. Biochem J. 1996 May 1;315(Pt 3):775–779. doi: 10.1042/bj3150775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Brady M. J., Bourbonais F. J., Saltiel A. R. The activation of glycogen synthase by insulin switches from kinase inhibition to phosphatase activation during adipogenesis in 3T3-L1 cells. J Biol Chem. 1998 Jun 5;273(23):14063–14066. doi: 10.1074/jbc.273.23.14063. [DOI] [PubMed] [Google Scholar]
  29. Brown E. J., Beal P. A., Keith C. T., Chen J., Shin T. B., Schreiber S. L. Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature. 1995 Oct 5;377(6548):441–446. doi: 10.1038/377441a0. [DOI] [PubMed] [Google Scholar]
  30. Brunn G. J., Hudson C. C., Sekulić A., Williams J. M., Hosoi H., Houghton P. J., Lawrence J. C., Jr, Abraham R. T. Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science. 1997 Jul 4;277(5322):99–101. doi: 10.1126/science.277.5322.99. [DOI] [PubMed] [Google Scholar]
  31. Brunn G. J., Williams J., Sabers C., Wiederrecht G., Lawrence J. C., Jr, Abraham R. T. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 1996 Oct 1;15(19):5256–5267. [PMC free article] [PubMed] [Google Scholar]
  32. Brüning J. C., Winnay J., Cheatham B., Kahn C. R. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells. Mol Cell Biol. 1997 Mar;17(3):1513–1521. doi: 10.1128/mcb.17.3.1513. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Burgering B. M., Coffer P. J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 1995 Aug 17;376(6541):599–602. doi: 10.1038/376599a0. [DOI] [PubMed] [Google Scholar]
  34. Burnett P. E., Barrow R. K., Cohen N. A., Snyder S. H., Sabatini D. M. RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1432–1437. doi: 10.1073/pnas.95.4.1432. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Calera M. R., Martinez C., Liu H., Jack A. K., Birnbaum M. J., Pilch P. F. Insulin increases the association of Akt-2 with Glut4-containing vesicles. J Biol Chem. 1998 Mar 27;273(13):7201–7204. doi: 10.1074/jbc.273.13.7201. [DOI] [PubMed] [Google Scholar]
  36. Carpenter C. L., Auger K. R., Chanudhuri M., Yoakim M., Schaffhausen B., Shoelson S., Cantley L. C. Phosphoinositide 3-kinase is activated by phosphopeptides that bind to the SH2 domains of the 85-kDa subunit. J Biol Chem. 1993 May 5;268(13):9478–9483. [PubMed] [Google Scholar]
  37. Carpenter C. L., Auger K. R., Duckworth B. C., Hou W. M., Schaffhausen B., Cantley L. C. A tightly associated serine/threonine protein kinase regulates phosphoinositide 3-kinase activity. Mol Cell Biol. 1993 Mar;13(3):1657–1665. doi: 10.1128/mcb.13.3.1657. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Chang H. W., Aoki M., Fruman D., Auger K. R., Bellacosa A., Tsichlis P. N., Cantley L. C., Roberts T. M., Vogt P. K. Transformation of chicken cells by the gene encoding the catalytic subunit of PI 3-kinase. Science. 1997 Jun 20;276(5320):1848–1850. doi: 10.1126/science.276.5320.1848. [DOI] [PubMed] [Google Scholar]
  39. Cheatham B., Kahn C. R. Insulin action and the insulin signaling network. Endocr Rev. 1995 Apr;16(2):117–142. doi: 10.1210/edrv-16-2-117. [DOI] [PubMed] [Google Scholar]
  40. Cheatham B., Vlahos C. J., Cheatham L., Wang L., Blenis J., Kahn C. R. Phosphatidylinositol 3-kinase activation is required for insulin stimulation of pp70 S6 kinase, DNA synthesis, and glucose transporter translocation. Mol Cell Biol. 1994 Jul;14(7):4902–4911. doi: 10.1128/mcb.14.7.4902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Chin J. E., Liu F., Roth R. A. Activation of protein kinase C alpha inhibits insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1. Mol Endocrinol. 1994 Jan;8(1):51–58. doi: 10.1210/mend.8.1.7512195. [DOI] [PubMed] [Google Scholar]
  42. Chung J., Grammer T. C., Lemon K. P., Kazlauskas A., Blenis J. PDGF- and insulin-dependent pp70S6k activation mediated by phosphatidylinositol-3-OH kinase. Nature. 1994 Jul 7;370(6484):71–75. doi: 10.1038/370071a0. [DOI] [PubMed] [Google Scholar]
  43. Clark S. F., Martin S., Carozzi A. J., Hill M. M., James D. E. Intracellular localization of phosphatidylinositide 3-kinase and insulin receptor substrate-1 in adipocytes: potential involvement of a membrane skeleton. J Cell Biol. 1998 Mar 9;140(5):1211–1225. doi: 10.1083/jcb.140.5.1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Clarke J. F., Young P. W., Yonezawa K., Kasuga M., Holman G. D. Inhibition of the translocation of GLUT1 and GLUT4 in 3T3-L1 cells by the phosphatidylinositol 3-kinase inhibitor, wortmannin. Biochem J. 1994 Jun 15;300(Pt 3):631–635. doi: 10.1042/bj3000631. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Cohen G. B., Ren R., Baltimore D. Modular binding domains in signal transduction proteins. Cell. 1995 Jan 27;80(2):237–248. doi: 10.1016/0092-8674(95)90406-9. [DOI] [PubMed] [Google Scholar]
  46. Cong L. N., Chen H., Li Y., Zhou L., McGibbon M. A., Taylor S. I., Quon M. J. Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol Endocrinol. 1997 Dec;11(13):1881–1890. doi: 10.1210/mend.11.13.0027. [DOI] [PubMed] [Google Scholar]
  47. Conricode K. M. Involvement of phosphatidylinositol 3-kinase in stimulation of glucose transport by growth factors in 3T3-L1 adipocytes. Biochem Mol Biol Int. 1995 Jul;36(4):835–843. [PubMed] [Google Scholar]
  48. Cormont M., Bortoluzzi M. N., Gautier N., Mari M., van Obberghen E., Le Marchand-Brustel Y. Potential role of Rab4 in the regulation of subcellular localization of Glut4 in adipocytes. Mol Cell Biol. 1996 Dec;16(12):6879–6886. doi: 10.1128/mcb.16.12.6879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Cormont M., Van Obberghen E., Zerial M., Le Marchand-Brustel Y. Insulin induces a change in Rab5 subcellular localization in adipocytes independently of phosphatidylinositol 3-kinase activation. Endocrinology. 1996 Aug;137(8):3408–3415. doi: 10.1210/endo.137.8.8754768. [DOI] [PubMed] [Google Scholar]
  50. Coso O. A., Chiariello M., Yu J. C., Teramoto H., Crespo P., Xu N., Miki T., Gutkind J. S. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell. 1995 Jun 30;81(7):1137–1146. doi: 10.1016/s0092-8674(05)80018-2. [DOI] [PubMed] [Google Scholar]
  51. Coughlin S. R., Escobedo J. A., Williams L. T. Role of phosphatidylinositol kinase in PDGF receptor signal transduction. Science. 1989 Mar 3;243(4895):1191–1194. doi: 10.1126/science.2466336. [DOI] [PubMed] [Google Scholar]
  52. Courtneidge S. A., Heber A. An 81 kd protein complexed with middle T antigen and pp60c-src: a possible phosphatidylinositol kinase. Cell. 1987 Sep 25;50(7):1031–1037. doi: 10.1016/0092-8674(87)90169-3. [DOI] [PubMed] [Google Scholar]
  53. Cross D. A., Alessi D. R., Cohen P., Andjelkovich M., Hemmings B. A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995 Dec 21;378(6559):785–789. doi: 10.1038/378785a0. [DOI] [PubMed] [Google Scholar]
  54. Cross D. A., Alessi D. R., Vandenheede J. R., McDowell H. E., Hundal H. S., Cohen P. The inhibition of glycogen synthase kinase-3 by insulin or insulin-like growth factor 1 in the rat skeletal muscle cell line L6 is blocked by wortmannin, but not by rapamycin: evidence that wortmannin blocks activation of the mitogen-activated protein kinase pathway in L6 cells between Ras and Raf. Biochem J. 1994 Oct 1;303(Pt 1):21–26. doi: 10.1042/bj3030021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Cross D. A., Watt P. W., Shaw M., van der Kaay J., Downes C. P., Holder J. C., Cohen P. Insulin activates protein kinase B, inhibits glycogen synthase kinase-3 and activates glycogen synthase by rapamycin-insensitive pathways in skeletal muscle and adipose tissue. FEBS Lett. 1997 Apr 7;406(1-2):211–215. doi: 10.1016/s0014-5793(97)00240-8. [DOI] [PubMed] [Google Scholar]
  56. Cross M. J., Stewart A., Hodgkin M. N., Kerr D. J., Wakelam M. J. Wortmannin and its structural analogue demethoxyviridin inhibit stimulated phospholipase A2 activity in Swiss 3T3 cells. Wortmannin is not a specific inhibitor of phosphatidylinositol 3-kinase. J Biol Chem. 1995 Oct 27;270(43):25352–25355. doi: 10.1074/jbc.270.43.25352. [DOI] [PubMed] [Google Scholar]
  57. Dalby K. N., Morrice N., Caudwell F. B., Avruch J., Cohen P. Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a/p90rsk that are inducible by MAPK. J Biol Chem. 1998 Jan 16;273(3):1496–1505. doi: 10.1074/jbc.273.3.1496. [DOI] [PubMed] [Google Scholar]
  58. Datta S. R., Dudek H., Tao X., Masters S., Fu H., Gotoh Y., Greenberg M. E. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell. 1997 Oct 17;91(2):231–241. doi: 10.1016/s0092-8674(00)80405-5. [DOI] [PubMed] [Google Scholar]
  59. De Camilli P., Emr S. D., McPherson P. S., Novick P. Phosphoinositides as regulators in membrane traffic. Science. 1996 Mar 15;271(5255):1533–1539. doi: 10.1126/science.271.5255.1533. [DOI] [PubMed] [Google Scholar]
  60. De Fea K., Roth R. A. Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase. J Biol Chem. 1997 Dec 12;272(50):31400–31406. doi: 10.1074/jbc.272.50.31400. [DOI] [PubMed] [Google Scholar]
  61. De Fea K., Roth R. A. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612. Biochemistry. 1997 Oct 21;36(42):12939–12947. doi: 10.1021/bi971157f. [DOI] [PubMed] [Google Scholar]
  62. DePaolo D., Reusch J. E., Carel K., Bhuripanyo P., Leitner J. W., Draznin B. Functional interactions of phosphatidylinositol 3-kinase with GTPase-activating protein in 3T3-L1 adipocytes. Mol Cell Biol. 1996 Apr;16(4):1450–1457. doi: 10.1128/mcb.16.4.1450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Deprez J., Vertommen D., Alessi D. R., Hue L., Rider M. H. Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J Biol Chem. 1997 Jul 11;272(28):17269–17275. doi: 10.1074/jbc.272.28.17269. [DOI] [PubMed] [Google Scholar]
  64. Dhand R., Hara K., Hiles I., Bax B., Gout I., Panayotou G., Fry M. J., Yonezawa K., Kasuga M., Waterfield M. D. PI 3-kinase: structural and functional analysis of intersubunit interactions. EMBO J. 1994 Feb 1;13(3):511–521. doi: 10.1002/j.1460-2075.1994.tb06289.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Dhand R., Hiles I., Panayotou G., Roche S., Fry M. J., Gout I., Totty N. F., Truong O., Vicendo P., Yonezawa K. PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J. 1994 Feb 1;13(3):522–533. doi: 10.1002/j.1460-2075.1994.tb06290.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Didichenko S. A., Tilton B., Hemmings B. A., Ballmer-Hofer K., Thelen M. Constitutive activation of protein kinase B and phosphorylation of p47phox by a membrane-targeted phosphoinositide 3-kinase. Curr Biol. 1996 Oct 1;6(10):1271–1278. doi: 10.1016/s0960-9822(02)70713-6. [DOI] [PubMed] [Google Scholar]
  67. Diggle T. A., Moule S. K., Avison M. B., Flynn A., Foulstone E. J., Proud C. G., Denton R. M. Both rapamycin-sensitive and -insensitive pathways are involved in the phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in response to insulin in rat epididymal fat-cells. Biochem J. 1996 Jun 1;316(Pt 2):447–453. doi: 10.1042/bj3160447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  68. Domin J., Dhand R., Waterfield M. D. Binding to the platelet-derived growth factor receptor transiently activates the p85alpha-p110alpha phosphoinositide 3-kinase complex in vivo. J Biol Chem. 1996 Aug 30;271(35):21614–21621. doi: 10.1074/jbc.271.35.21614. [DOI] [PubMed] [Google Scholar]
  69. Domin J., Pages F., Volinia S., Rittenhouse S. E., Zvelebil M. J., Stein R. C., Waterfield M. D. Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin. Biochem J. 1997 Aug 15;326(Pt 1):139–147. doi: 10.1042/bj3260139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Dudek H., Datta S. R., Franke T. F., Birnbaum M. J., Yao R., Cooper G. M., Segal R. A., Kaplan D. R., Greenberg M. E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 1997 Jan 31;275(5300):661–665. doi: 10.1126/science.275.5300.661. [DOI] [PubMed] [Google Scholar]
  71. Eldar-Finkelman H., Krebs E. G. Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc Natl Acad Sci U S A. 1997 Sep 2;94(18):9660–9664. doi: 10.1073/pnas.94.18.9660. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Endemann G., Yonezawa K., Roth R. A. Phosphatidylinositol kinase or an associated protein is a substrate for the insulin receptor tyrosine kinase. J Biol Chem. 1990 Jan 5;265(1):396–400. [PubMed] [Google Scholar]
  73. Escobedo J. A., Navankasattusas S., Kavanaugh W. M., Milfay D., Fried V. A., Williams L. T. cDNA cloning of a novel 85 kd protein that has SH2 domains and regulates binding of PI3-kinase to the PDGF beta-receptor. Cell. 1991 Apr 5;65(1):75–82. doi: 10.1016/0092-8674(91)90409-r. [DOI] [PubMed] [Google Scholar]
  74. Falasca M., Logan S. K., Lehto V. P., Baccante G., Lemmon M. A., Schlessinger J. Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting. EMBO J. 1998 Jan 15;17(2):414–422. doi: 10.1093/emboj/17.2.414. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Fingar D. C., Hausdorff S. F., Blenis J., Birnbaum M. J. Dissociation of pp70 ribosomal protein S6 kinase from insulin-stimulated glucose transport in 3T3-L1 adipocytes. J Biol Chem. 1993 Feb 5;268(4):3005–3008. [PubMed] [Google Scholar]
  76. Folli F., Saad M. J., Backer J. M., Kahn C. R. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. J Clin Invest. 1993 Oct;92(4):1787–1794. doi: 10.1172/JCI116768. [DOI] [PMC free article] [PubMed] [Google Scholar]
  77. Franke T. F., Kaplan D. R., Cantley L. C., Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science. 1997 Jan 31;275(5300):665–668. doi: 10.1126/science.275.5300.665. [DOI] [PubMed] [Google Scholar]
  78. Franke T. F., Yang S. I., Chan T. O., Datta K., Kazlauskas A., Morrison D. K., Kaplan D. R., Tsichlis P. N. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 1995 Jun 2;81(5):727–736. doi: 10.1016/0092-8674(95)90534-0. [DOI] [PubMed] [Google Scholar]
  79. Freund G. G., Wittig J. G., Mooney R. A. The PI3-kinase serine kinase phosphorylates its p85 subunit and IRS-1 in PI3-kinase/IRS-1 complexes. Biochem Biophys Res Commun. 1995 Jan 5;206(1):272–278. doi: 10.1006/bbrc.1995.1038. [DOI] [PubMed] [Google Scholar]
  80. Frevert E. U., Kahn B. B. Differential effects of constitutively active phosphatidylinositol 3-kinase on glucose transport, glycogen synthase activity, and DNA synthesis in 3T3-L1 adipocytes. Mol Cell Biol. 1997 Jan;17(1):190–198. doi: 10.1128/mcb.17.1.190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  81. Fruman D. A., Cantley L. C., Carpenter C. L. Structural organization and alternative splicing of the murine phosphoinositide 3-kinase p85 alpha gene. Genomics. 1996 Oct 1;37(1):113–121. doi: 10.1006/geno.1996.0527. [DOI] [PubMed] [Google Scholar]
  82. Fry M. J., Panayotou G., Dhand R., Ruiz-Larrea F., Gout I., Nguyen O., Courtneidge S. A., Waterfield M. D. Purification and characterization of a phosphatidylinositol 3-kinase complex from bovine brain by using phosphopeptide affinity columns. Biochem J. 1992 Dec 1;288(Pt 2):383–393. doi: 10.1042/bj2880383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  83. Fujita N., Kaku K., Okubo M., Nagasaka Y., Kaneko T. Insulin stimulates protein synthesis of glycogen synthase in rat hepatoma H4 cells associated with acceleration of translation rate. Endocr J. 1996 Jun;43(3):313–320. doi: 10.1507/endocrj.43.313. [DOI] [PubMed] [Google Scholar]
  84. Gaidarov I., Chen Q., Falck J. R., Reddy K. K., Keen J. H. A functional phosphatidylinositol 3,4,5-trisphosphate/phosphoinositide binding domain in the clathrin adaptor AP-2 alpha subunit. Implications for the endocytic pathway. J Biol Chem. 1996 Aug 23;271(34):20922–20929. doi: 10.1074/jbc.271.34.20922. [DOI] [PubMed] [Google Scholar]
  85. Gallego M. E., Balvay L., Brody E. cis-acting sequences involved in exon selection in the chicken beta-tropomyosin gene. Mol Cell Biol. 1992 Dec;12(12):5415–5425. doi: 10.1128/mcb.12.12.5415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  86. Gingras A. C., Kennedy S. G., O'Leary M. A., Sonenberg N., Hay N. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev. 1998 Feb 15;12(4):502–513. doi: 10.1101/gad.12.4.502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  87. Giorgetti S., Ballotti R., Kowalski-Chauvel A., Tartare S., Van Obberghen E. The insulin and insulin-like growth factor-I receptor substrate IRS-1 associates with and activates phosphatidylinositol 3-kinase in vitro. J Biol Chem. 1993 Apr 5;268(10):7358–7364. [PubMed] [Google Scholar]
  88. Goodyear L. J., Giorgino F., Sherman L. A., Carey J., Smith R. J., Dohm G. L. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects. J Clin Invest. 1995 May;95(5):2195–2204. doi: 10.1172/JCI117909. [DOI] [PMC free article] [PubMed] [Google Scholar]
  89. Gould G. W., Holman G. D. The glucose transporter family: structure, function and tissue-specific expression. Biochem J. 1993 Oct 15;295(Pt 2):329–341. doi: 10.1042/bj2950329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  90. Gout I., Dhand R., Hiles I. D., Fry M. J., Panayotou G., Das P., Truong O., Totty N. F., Hsuan J., Booker G. W. The GTPase dynamin binds to and is activated by a subset of SH3 domains. Cell. 1993 Oct 8;75(1):25–36. [PubMed] [Google Scholar]
  91. Gout I., Dhand R., Panayotou G., Fry M. J., Hiles I., Otsu M., Waterfield M. D. Expression and characterization of the p85 subunit of the phosphatidylinositol 3-kinase complex and a related p85 beta protein by using the baculovirus expression system. Biochem J. 1992 Dec 1;288(Pt 2):395–405. doi: 10.1042/bj2880395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  92. Guilherme A., Klarlund J. K., Krystal G., Czech M. P. Regulation of phosphatidylinositol 3,4,5-trisphosphate 5'-phosphatase activity by insulin. J Biol Chem. 1996 Nov 22;271(47):29533–29536. doi: 10.1074/jbc.271.47.29533. [DOI] [PubMed] [Google Scholar]
  93. Guinebault C., Payrastre B., Racaud-Sultan C., Mazarguil H., Breton M., Mauco G., Plantavid M., Chap H. Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85 alpha with actin filaments and focal adhesion kinase. J Cell Biol. 1995 May;129(3):831–842. doi: 10.1083/jcb.129.3.831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  94. Hadari Y. R., Tzahar E., Nadiv O., Rothenberg P., Roberts C. T., Jr, LeRoith D., Yarden Y., Zick Y. Insulin and insulinomimetic agents induce activation of phosphatidylinositol 3'-kinase upon its association with pp185 (IRS-1) in intact rat livers. J Biol Chem. 1992 Sep 5;267(25):17483–17486. [PubMed] [Google Scholar]
  95. Hammonds-Odie L. P., Jackson T. R., Profit A. A., Blader I. J., Turck C. W., Prestwich G. D., Theibert A. B. Identification and cloning of centaurin-alpha. A novel phosphatidylinositol 3,4,5-trisphosphate-binding protein from rat brain. J Biol Chem. 1996 Aug 2;271(31):18859–18868. doi: 10.1074/jbc.271.31.18859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Hansen T., Andersen C. B., Echwald S. M., Urhammer S. A., Clausen J. O., Vestergaard H., Owens D., Hansen L., Pedersen O. Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index. Diabetes. 1997 Mar;46(3):494–501. doi: 10.2337/diab.46.3.494. [DOI] [PubMed] [Google Scholar]
  97. Hao W., Tan Z., Prasad K., Reddy K. K., Chen J., Prestwich G. D., Falck J. R., Shears S. B., Lafer E. M. Regulation of AP-3 function by inositides. Identification of phosphatidylinositol 3,4,5-trisphosphate as a potent ligand. J Biol Chem. 1997 Mar 7;272(10):6393–6398. doi: 10.1074/jbc.272.10.6393. [DOI] [PubMed] [Google Scholar]
  98. Hara K., Yonezawa K., Sakaue H., Ando A., Kotani K., Kitamura T., Kitamura Y., Ueda H., Stephens L., Jackson T. R. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells. Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7415–7419. doi: 10.1073/pnas.91.16.7415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  99. Hartley D., Meisner H., Corvera S. Specific association of the beta isoform of the p85 subunit of phosphatidylinositol-3 kinase with the proto-oncogene c-cbl. J Biol Chem. 1995 Aug 4;270(31):18260–18263. doi: 10.1074/jbc.270.31.18260. [DOI] [PubMed] [Google Scholar]
  100. Haruta T., Morris A. J., Vollenweider P., Nelson J. G., Rose D. W., Mueckler M., Olefsky J. M. Ligand-independent GLUT4 translocation induced by guanosine 5'-O-(3-thiotriphosphate) involves tyrosine phosphorylation. Endocrinology. 1998 Jan;139(1):358–364. doi: 10.1210/endo.139.1.5698. [DOI] [PubMed] [Google Scholar]
  101. Hawkins P. T., Eguinoa A., Qiu R. G., Stokoe D., Cooke F. T., Walters R., Wennström S., Claesson-Welsh L., Evans T., Symons M. PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase. Curr Biol. 1995 Apr 1;5(4):393–403. doi: 10.1016/s0960-9822(95)00080-7. [DOI] [PubMed] [Google Scholar]
  102. Hawkins P. T., Jackson T. R., Stephens L. R. Platelet-derived growth factor stimulates synthesis of PtdIns(3,4,5)P3 by activating a PtdIns(4,5)P2 3-OH kinase. Nature. 1992 Jul 9;358(6382):157–159. doi: 10.1038/358157a0. [DOI] [PubMed] [Google Scholar]
  103. Hayashi H., Kamohara S., Nishioka Y., Kanai F., Miyake N., Fukui Y., Shibasaki F., Takenawa T., Ebina Y. Insulin treatment stimulates the tyrosine phosphorylation of the alpha-type 85-kDa subunit of phosphatidylinositol 3-kinase in vivo. J Biol Chem. 1992 Nov 5;267(31):22575–22580. [PubMed] [Google Scholar]
  104. Hayashi H., Nishioka Y., Kamohara S., Kanai F., Ishii K., Fukui Y., Shibasaki F., Takenawa T., Kido H., Katsunuma N. The alpha-type 85-kDa subunit of phosphatidylinositol 3-kinase is phosphorylated at tyrosines 368, 580, and 607 by the insulin receptor. J Biol Chem. 1993 Apr 5;268(10):7107–7117. [PubMed] [Google Scholar]
  105. He W., O'Neill T. J., Gustafson T. A. Distinct modes of interaction of SHC and insulin receptor substrate-1 with the insulin receptor NPEY region via non-SH2 domains. J Biol Chem. 1995 Oct 6;270(40):23258–23262. doi: 10.1074/jbc.270.40.23258. [DOI] [PubMed] [Google Scholar]
  106. Heller-Harrison R. A., Morin M., Czech M. P. Insulin regulation of membrane-associated insulin receptor substrate 1. J Biol Chem. 1995 Oct 13;270(41):24442–24450. doi: 10.1074/jbc.270.41.24442. [DOI] [PubMed] [Google Scholar]
  107. Hemati N., Ross S. E., Erickson R. L., Groblewski G. E., MacDougald O. A. Signaling pathways through which insulin regulates CCAAT/enhancer binding protein alpha (C/EBPalpha) phosphorylation and gene expression in 3T3-L1 adipocytes. Correlation with GLUT4 gene expression. J Biol Chem. 1997 Oct 10;272(41):25913–25919. doi: 10.1074/jbc.272.41.25913. [DOI] [PubMed] [Google Scholar]
  108. Herbst J. J., Andrews G., Contillo L., Lamphere L., Gardner J., Lienhard G. E., Gibbs E. M. Potent activation of phosphatidylinositol 3'-kinase by simple phosphotyrosine peptides derived from insulin receptor substrate 1 containing two YMXM motifs for binding SH2 domains. Biochemistry. 1994 Aug 16;33(32):9376–9381. doi: 10.1021/bi00198a002. [DOI] [PubMed] [Google Scholar]
  109. Hiles I. D., Otsu M., Volinia S., Fry M. J., Gout I., Dhand R., Panayotou G., Ruiz-Larrea F., Thompson A., Totty N. F. Phosphatidylinositol 3-kinase: structure and expression of the 110 kd catalytic subunit. Cell. 1992 Aug 7;70(3):419–429. doi: 10.1016/0092-8674(92)90166-a. [DOI] [PubMed] [Google Scholar]
  110. Holgado-Madruga M., Emlet D. R., Moscatello D. K., Godwin A. K., Wong A. J. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature. 1996 Feb 8;379(6565):560–564. doi: 10.1038/379560a0. [DOI] [PubMed] [Google Scholar]
  111. Holman G. D., Kasuga M. From receptor to transporter: insulin signalling to glucose transport. Diabetologia. 1997 Sep;40(9):991–1003. doi: 10.1007/s001250050780. [DOI] [PubMed] [Google Scholar]
  112. Hosomi Y., Shii K., Ogawa W., Matsuba H., Yoshida M., Okada Y., Yokono K., Kasuga M., Baba S., Roth R. A. Characterization of a 60-kilodalton substrate of the insulin receptor kinase. J Biol Chem. 1994 Apr 15;269(15):11498–11502. [PubMed] [Google Scholar]
  113. Hotamisligil G. S., Peraldi P., Budavari A., Ellis R., White M. F., Spiegelman B. M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science. 1996 Feb 2;271(5249):665–668. doi: 10.1126/science.271.5249.665. [DOI] [PubMed] [Google Scholar]
  114. Hu P., Mondino A., Skolnik E. Y., Schlessinger J. Cloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85. Mol Cell Biol. 1993 Dec;13(12):7677–7688. doi: 10.1128/mcb.13.12.7677. [DOI] [PMC free article] [PubMed] [Google Scholar]
  115. Hu Q., Klippel A., Muslin A. J., Fantl W. J., Williams L. T. Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase. Science. 1995 Apr 7;268(5207):100–102. doi: 10.1126/science.7701328. [DOI] [PubMed] [Google Scholar]
  116. Hunter S., Koch B. L., Anderson S. M. Phosphorylation of cbl after stimulation of Nb2 cells with prolactin and its association with phosphatidylinositol 3-kinase. Mol Endocrinol. 1997 Aug;11(9):1213–1222. doi: 10.1210/mend.11.9.9980. [DOI] [PubMed] [Google Scholar]
  117. Hurel S. J., Rochford J. J., Borthwick A. C., Wells A. M., Vandenheede J. R., Turnbull D. M., Yeaman S. J. Insulin action in cultured human myoblasts: contribution of different signalling pathways to regulation of glycogen synthesis. Biochem J. 1996 Dec 15;320(Pt 3):871–877. doi: 10.1042/bj3200871. [DOI] [PMC free article] [PubMed] [Google Scholar]
  118. Inukai K., Anai M., Van Breda E., Hosaka T., Katagiri H., Funaki M., Fukushima Y., Ogihara T., Yazaki Y., Kikuchi A novel 55-kDa regulatory subunit for phosphatidylinositol 3-kinase structurally similar to p55PIK Is generated by alternative splicing of the p85alpha gene. J Biol Chem. 1996 Mar 8;271(10):5317–5320. doi: 10.1074/jbc.271.10.5317. [DOI] [PubMed] [Google Scholar]
  119. Inukai K., Funaki M., Ogihara T., Katagiri H., Kanda A., Anai M., Fukushima Y., Hosaka T., Suzuki M., Shin B. C. p85alpha gene generates three isoforms of regulatory subunit for phosphatidylinositol 3-kinase (PI 3-Kinase), p50alpha, p55alpha, and p85alpha, with different PI 3-kinase activity elevating responses to insulin. J Biol Chem. 1997 Mar 21;272(12):7873–7882. doi: 10.1074/jbc.272.12.7873. [DOI] [PubMed] [Google Scholar]
  120. Isakoff S. J., Taha C., Rose E., Marcusohn J., Klip A., Skolnik E. Y. The inability of phosphatidylinositol 3-kinase activation to stimulate GLUT4 translocation indicates additional signaling pathways are required for insulin-stimulated glucose uptake. Proc Natl Acad Sci U S A. 1995 Oct 24;92(22):10247–10251. doi: 10.1073/pnas.92.22.10247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  121. Jackson S. P., Schoenwaelder S. M., Matzaris M., Brown S., Mitchell C. A. Phosphatidylinositol 3,4,5-trisphosphate is a substrate for the 75 kDa inositol polyphosphate 5-phosphatase and a novel 5-phosphatase which forms a complex with the p85/p110 form of phosphoinositide 3-kinase. EMBO J. 1995 Sep 15;14(18):4490–4500. doi: 10.1002/j.1460-2075.1995.tb00128.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  122. James S. R., Downes C. P., Gigg R., Grove S. J., Holmes A. B., Alessi D. R. Specific binding of the Akt-1 protein kinase to phosphatidylinositol 3,4,5-trisphosphate without subsequent activation. Biochem J. 1996 May 1;315(Pt 3):709–713. doi: 10.1042/bj3150709. [DOI] [PMC free article] [PubMed] [Google Scholar]
  123. Jess T. J., Belham C. M., Thomson F. J., Scott P. H., Plevin R. J., Gould G. W. Phosphatidylinositol 3'-kinase, but not p70 ribosomal S6 kinase, is involved in membrane protein recycling: wortmannin inhibits glucose transport and downregulates cell-surface transferrin receptor numbers independently of any effect on fluid-phase endocytosis in fibroblasts. Cell Signal. 1996 Jun;8(4):297–304. doi: 10.1016/0898-6568(96)00054-x. [DOI] [PubMed] [Google Scholar]
  124. Jhun B. H., Rose D. W., Seely B. L., Rameh L., Cantley L., Saltiel A. R., Olefsky J. M. Microinjection of the SH2 domain of the 85-kilodalton subunit of phosphatidylinositol 3-kinase inhibits insulin-induced DNA synthesis and c-fos expression. Mol Cell Biol. 1994 Nov;14(11):7466–7475. doi: 10.1128/mcb.14.11.7466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  125. Jiang T., Sweeney G., Rudolf M. T., Klip A., Traynor-Kaplan A., Tsien R. Y. Membrane-permeant esters of phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1998 May 1;273(18):11017–11024. doi: 10.1074/jbc.273.18.11017. [DOI] [PubMed] [Google Scholar]
  126. Jimenez C., Jones D. R., Rodríguez-Viciana P., Gonzalez-García A., Leonardo E., Wennström S., von Kobbe C., Toran J. L., R-Borlado L., Calvo V. Identification and characterization of a new oncogene derived from the regulatory subunit of phosphoinositide 3-kinase. EMBO J. 1998 Feb 2;17(3):743–753. doi: 10.1093/emboj/17.3.743. [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Kaliman P., Canicio J., Shepherd P. R., Beeton C. A., Testar X., Palacín M., Zorzano A. Insulin-like growth factors require phosphatidylinositol 3-kinase to signal myogenesis: dominant negative p85 expression blocks differentiation of L6E9 muscle cells. Mol Endocrinol. 1998 Jan;12(1):66–77. doi: 10.1210/mend.12.1.0047. [DOI] [PubMed] [Google Scholar]
  128. Kaliman P., Viñals F., Testar X., Palacín M., Zorzano A. Disruption of GLUT1 glucose carrier trafficking in L6E9 and Sol8 myoblasts by the phosphatidylinositol 3-kinase inhibitor wortmannin. Biochem J. 1995 Dec 1;312(Pt 2):471–477. doi: 10.1042/bj3120471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  129. Kanai F., Ito K., Todaka M., Hayashi H., Kamohara S., Ishii K., Okada T., Hazeki O., Ui M., Ebina Y. Insulin-stimulated GLUT4 translocation is relevant to the phosphorylation of IRS-1 and the activity of PI3-kinase. Biochem Biophys Res Commun. 1993 Sep 15;195(2):762–768. doi: 10.1006/bbrc.1993.2111. [DOI] [PubMed] [Google Scholar]
  130. Kanety H., Feinstein R., Papa M. Z., Hemi R., Karasik A. Tumor necrosis factor alpha-induced phosphorylation of insulin receptor substrate-1 (IRS-1). Possible mechanism for suppression of insulin-stimulated tyrosine phosphorylation of IRS-1. J Biol Chem. 1995 Oct 6;270(40):23780–23784. doi: 10.1074/jbc.270.40.23780. [DOI] [PubMed] [Google Scholar]
  131. Kapeller R., Toker A., Cantley L. C., Carpenter C. L. Phosphoinositide 3-kinase binds constitutively to alpha/beta-tubulin and binds to gamma-tubulin in response to insulin. J Biol Chem. 1995 Oct 27;270(43):25985–25991. doi: 10.1074/jbc.270.43.25985. [DOI] [PubMed] [Google Scholar]
  132. Kaplan D. R., Whitman M., Schaffhausen B., Pallas D. C., White M., Cantley L., Roberts T. M. Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity. Cell. 1987 Sep 25;50(7):1021–1029. doi: 10.1016/0092-8674(87)90168-1. [DOI] [PubMed] [Google Scholar]
  133. Katagiri H., Asano T., Ishihara H., Inukai K., Shibasaki Y., Kikuchi M., Yazaki Y., Oka Y. Overexpression of catalytic subunit p110alpha of phosphatidylinositol 3-kinase increases glucose transport activity with translocation of glucose transporters in 3T3-L1 adipocytes. J Biol Chem. 1996 Jul 19;271(29):16987–16990. doi: 10.1074/jbc.271.29.16987. [DOI] [PubMed] [Google Scholar]
  134. Kauffmann-Zeh A., Rodriguez-Viciana P., Ulrich E., Gilbert C., Coffer P., Downward J., Evan G. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature. 1997 Feb 6;385(6616):544–548. doi: 10.1038/385544a0. [DOI] [PubMed] [Google Scholar]
  135. Kavanaugh W. M., Turck C. W., Klippel A., Williams L. T. Tyrosine 508 of the 85-kilodalton subunit of phosphatidylinositol 3-kinase is phosphorylated by the platelet-derived growth factor receptor. Biochemistry. 1994 Sep 13;33(36):11046–11050. doi: 10.1021/bi00202a026. [DOI] [PubMed] [Google Scholar]
  136. Kazlauskas A., Cooper J. A. Phosphorylation of the PDGF receptor beta subunit creates a tight binding site for phosphatidylinositol 3 kinase. EMBO J. 1990 Oct;9(10):3279–3286. doi: 10.1002/j.1460-2075.1990.tb07527.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  137. Kelly K. L., Ruderman N. B., Chen K. S. Phosphatidylinositol-3-kinase in isolated rat adipocytes. Activation by insulin and subcellular distribution. J Biol Chem. 1992 Feb 15;267(5):3423–3428. [PubMed] [Google Scholar]
  138. Kelly K. L., Ruderman N. B. Insulin-stimulated phosphatidylinositol 3-kinase. Association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density membrane vesicle. J Biol Chem. 1993 Feb 25;268(6):4391–4398. [PubMed] [Google Scholar]
  139. Kennedy S. G., Wagner A. J., Conzen S. D., Jordán J., Bellacosa A., Tsichlis P. N., Hay N. The PI 3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev. 1997 Mar 15;11(6):701–713. doi: 10.1101/gad.11.6.701. [DOI] [PubMed] [Google Scholar]
  140. Kerouz N. J., Hörsch D., Pons S., Kahn C. R. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest. 1997 Dec 15;100(12):3164–3172. doi: 10.1172/JCI119872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  141. Khwaja A., Rodriguez-Viciana P., Wennström S., Warne P. H., Downward J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B/Akt cellular survival pathway. EMBO J. 1997 May 15;16(10):2783–2793. doi: 10.1093/emboj/16.10.2783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  142. Klarlund J. K., Guilherme A., Holik J. J., Virbasius J. V., Chawla A., Czech M. P. Signaling by phosphoinositide-3,4,5-trisphosphate through proteins containing pleckstrin and Sec7 homology domains. Science. 1997 Mar 28;275(5308):1927–1930. doi: 10.1126/science.275.5308.1927. [DOI] [PubMed] [Google Scholar]
  143. Klinghoffer R. A., Duckworth B., Valius M., Cantley L., Kazlauskas A. Platelet-derived growth factor-dependent activation of phosphatidylinositol 3-kinase is regulated by receptor binding of SH2-domain-containing proteins which influence Ras activity. Mol Cell Biol. 1996 Oct;16(10):5905–5914. doi: 10.1128/mcb.16.10.5905. [DOI] [PMC free article] [PubMed] [Google Scholar]
  144. Klippel A., Kavanaugh W. M., Pot D., Williams L. T. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol Cell Biol. 1997 Jan;17(1):338–344. doi: 10.1128/mcb.17.1.338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  145. Klippel A., Reinhard C., Kavanaugh W. M., Apell G., Escobedo M. A., Williams L. T. Membrane localization of phosphatidylinositol 3-kinase is sufficient to activate multiple signal-transducing kinase pathways. Mol Cell Biol. 1996 Aug;16(8):4117–4127. doi: 10.1128/mcb.16.8.4117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  146. Kobayashi M., Nagata S., Kita Y., Nakatsu N., Ihara S., Kaibuchi K., Kuroda S., Ui M., Iba H., Konishi H. Expression of a constitutively active phosphatidylinositol 3-kinase induces process formation in rat PC12 cells. Use of Cre/loxP recombination system. J Biol Chem. 1997 Jun 27;272(26):16089–16092. doi: 10.1074/jbc.272.26.16089. [DOI] [PubMed] [Google Scholar]
  147. Kohn A. D., Barthel A., Kovacina K. S., Boge A., Wallach B., Summers S. A., Birnbaum M. J., Scott P. H., Lawrence J. C., Jr, Roth R. A. Construction and characterization of a conditionally active version of the serine/threonine kinase Akt. J Biol Chem. 1998 May 8;273(19):11937–11943. doi: 10.1074/jbc.273.19.11937. [DOI] [PubMed] [Google Scholar]
  148. Kohn A. D., Summers S. A., Birnbaum M. J., Roth R. A. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem. 1996 Dec 6;271(49):31372–31378. doi: 10.1074/jbc.271.49.31372. [DOI] [PubMed] [Google Scholar]
  149. Kosaki A., Yamada K., Suga J., Otaka A., Kuzuya H. 14-3-3beta protein associates with insulin receptor substrate 1 and decreases insulin-stimulated phosphatidylinositol 3'-kinase activity in 3T3L1 adipocytes. J Biol Chem. 1998 Jan 9;273(2):940–944. doi: 10.1074/jbc.273.2.940. [DOI] [PubMed] [Google Scholar]
  150. Kotani K., Carozzi A. J., Sakaue H., Hara K., Robinson L. J., Clark S. F., Yonezawa K., James D. E., Kasuga M. Requirement for phosphoinositide 3-kinase in insulin-stimulated GLUT4 translocation in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 1995 Apr 6;209(1):343–348. doi: 10.1006/bbrc.1995.1509. [DOI] [PubMed] [Google Scholar]
  151. Kotani K., Yonezawa K., Hara K., Ueda H., Kitamura Y., Sakaue H., Ando A., Chavanieu A., Calas B., Grigorescu F. Involvement of phosphoinositide 3-kinase in insulin- or IGF-1-induced membrane ruffling. EMBO J. 1994 May 15;13(10):2313–2321. doi: 10.1002/j.1460-2075.1994.tb06515.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  152. Kulik G., Klippel A., Weber M. J. Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol. 1997 Mar;17(3):1595–1606. doi: 10.1128/mcb.17.3.1595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  153. Lam K., Carpenter C. L., Ruderman N. B., Friel J. C., Kelly K. L. The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by Wortmannin. J Biol Chem. 1994 Aug 12;269(32):20648–20652. [PubMed] [Google Scholar]
  154. Lavan B. E., Fantin V. R., Chang E. T., Lane W. S., Keller S. R., Lienhard G. E. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J Biol Chem. 1997 Aug 22;272(34):21403–21407. doi: 10.1074/jbc.272.34.21403. [DOI] [PubMed] [Google Scholar]
  155. Lavan B. E., Kuhné M. R., Garner C. W., Anderson D., Reedijk M., Pawson T., Lienhard G. E. The association of insulin-elicited phosphotyrosine proteins with src homology 2 domains. J Biol Chem. 1992 Jun 5;267(16):11631–11636. [PubMed] [Google Scholar]
  156. Lavan B. E., Lane W. S., Lienhard G. E. The 60-kDa phosphotyrosine protein in insulin-treated adipocytes is a new member of the insulin receptor substrate family. J Biol Chem. 1997 Apr 25;272(17):11439–11443. doi: 10.1074/jbc.272.17.11439. [DOI] [PubMed] [Google Scholar]
  157. Lavan B. E., Lienhard G. E. The insulin-elicited 60-kDa phosphotyrosine protein in rat adipocytes is associated with phosphatidylinositol 3-kinase. J Biol Chem. 1993 Mar 15;268(8):5921–5928. [PubMed] [Google Scholar]
  158. Lawrence J. C., Jr, Roach P. J. New insights into the role and mechanism of glycogen synthase activation by insulin. Diabetes. 1997 Apr;46(4):541–547. doi: 10.2337/diab.46.4.541. [DOI] [PubMed] [Google Scholar]
  159. Le Marchand-Brustel Y., Gautier N., Cormont M., Van Obberghen E. Wortmannin inhibits the action of insulin but not that of okadaic acid in skeletal muscle: comparison with fat cells. Endocrinology. 1995 Aug;136(8):3564–3570. doi: 10.1210/endo.136.8.7628394. [DOI] [PubMed] [Google Scholar]
  160. Lefebvre V., Méchin M. C., Louckx M. P., Rider M. H., Hue L. Signaling pathway involved in the activation of heart 6-phosphofructo-2-kinase by insulin. J Biol Chem. 1996 Sep 13;271(37):22289–22292. doi: 10.1074/jbc.271.37.22289. [DOI] [PubMed] [Google Scholar]
  161. Levy-Toledano R., Blaettler D. H., LaRochelle W. J., Taylor S. I. Insulin-induced activation of phosphatidylinositol (PI) 3-kinase. Insulin-induced phosphorylation of insulin receptors and insulin receptor substrate-1 displaces phosphorylated platelet-derived growth factor receptors from binding sites on PI 3-kinase. J Biol Chem. 1995 Dec 15;270(50):30018–30022. doi: 10.1074/jbc.270.50.30018. [DOI] [PubMed] [Google Scholar]
  162. Levy-Toledano R., Taouis M., Blaettler D. H., Gorden P., Taylor S. I. Insulin-induced activation of phosphatidyl inositol 3-kinase. Demonstration that the p85 subunit binds directly to the COOH terminus of the insulin receptor in intact cells. J Biol Chem. 1994 Dec 9;269(49):31178–31182. [PubMed] [Google Scholar]
  163. Lioubin M. N., Algate P. A., Tsai S., Carlberg K., Aebersold A., Rohrschneider L. R. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev. 1996 May 1;10(9):1084–1095. doi: 10.1101/gad.10.9.1084. [DOI] [PubMed] [Google Scholar]
  164. Liu R., Livingston J. N. Association of the insulin receptor and phosphatidylinositol 3-kinase requires a third component. Biochem J. 1994 Jan 15;297(Pt 2):335–342. doi: 10.1042/bj2970335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  165. Liu X., Marengere L. E., Koch C. A., Pawson T. The v-Src SH3 domain binds phosphatidylinositol 3'-kinase. Mol Cell Biol. 1993 Sep;13(9):5225–5232. doi: 10.1128/mcb.13.9.5225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  166. Lopez-Ilasaca M., Li W., Uren A., Yu J. C., Kazlauskas A., Gutkind J. S., Heidaran M. A. Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF. Biochem Biophys Res Commun. 1997 Mar 17;232(2):273–277. doi: 10.1006/bbrc.1997.6289. [DOI] [PubMed] [Google Scholar]
  167. Lowy D. R., Willumsen B. M. Function and regulation of ras. Annu Rev Biochem. 1993;62:851–891. doi: 10.1146/annurev.bi.62.070193.004223. [DOI] [PubMed] [Google Scholar]
  168. Lu P. J., Chen C. S. Selective recognition of phosphatidylinositol 3,4,5-trisphosphate by a synthetic peptide. J Biol Chem. 1997 Jan 3;272(1):466–472. doi: 10.1074/jbc.272.1.466. [DOI] [PubMed] [Google Scholar]
  169. Lu P. J., Shieh W. R., Rhee S. G., Yin H. L., Chen C. S. Lipid products of phosphoinositide 3-kinase bind human profilin with high affinity. Biochemistry. 1996 Nov 5;35(44):14027–14034. doi: 10.1021/bi961878z. [DOI] [PubMed] [Google Scholar]
  170. Lund S., Holman G. D., Schmitz O., Pedersen O. Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin. Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5817–5821. doi: 10.1073/pnas.92.13.5817. [DOI] [PMC free article] [PubMed] [Google Scholar]
  171. Magun R., Burgering B. M., Coffer P. J., Pardasani D., Lin Y., Chabot J., Sorisky A. Expression of a constitutively activated form of protein kinase B (c-Akt) in 3T3-L1 preadipose cells causes spontaneous differentiation. Endocrinology. 1996 Aug;137(8):3590–3593. doi: 10.1210/endo.137.8.8754791. [DOI] [PubMed] [Google Scholar]
  172. Marte B. M., Rodriguez-Viciana P., Wennström S., Warne P. H., Downward J. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways. Curr Biol. 1997 Jan 1;7(1):63–70. doi: 10.1016/s0960-9822(06)00028-5. [DOI] [PubMed] [Google Scholar]
  173. McIlroy J., Chen D., Wjasow C., Michaeli T., Backer J. M. Specific activation of p85-p110 phosphatidylinositol 3'-kinase stimulates DNA synthesis by ras- and p70 S6 kinase-dependent pathways. Mol Cell Biol. 1997 Jan;17(1):248–255. doi: 10.1128/mcb.17.1.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Milarski K. L., Lazar D. F., Wiese R. J., Saltiel A. R. Detection of a 60 kDa tyrosine-phosphorylated protein in insulin-stimulated hepatoma cells that associates with the SH2 domain of phosphatidylinositol 3-kinase. Biochem J. 1995 Jun 1;308(Pt 2):579–583. doi: 10.1042/bj3080579. [DOI] [PMC free article] [PubMed] [Google Scholar]
  175. Mithieux G., Daniele N., Payrastre B., Zitoun C. Liver microsomal glucose-6-phosphatase is competitively inhibited by the lipid products of phosphatidylinositol 3-kinase. J Biol Chem. 1998 Jan 2;273(1):17–19. doi: 10.1074/jbc.273.1.17. [DOI] [PubMed] [Google Scholar]
  176. Monfar M., Lemon K. P., Grammer T. C., Cheatham L., Chung J., Vlahos C. J., Blenis J. Activation of pp70/85 S6 kinases in interleukin-2-responsive lymphoid cells is mediated by phosphatidylinositol 3-kinase and inhibited by cyclic AMP. Mol Cell Biol. 1995 Jan;15(1):326–337. doi: 10.1128/mcb.15.1.326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  177. Mora S., Monden I., Zorzano A., Keller K. Heterologous expression of rab4 reduces glucose transport and GLUT4 abundance at the cell surface in oocytes. Biochem J. 1997 Jun 1;324(Pt 2):455–459. doi: 10.1042/bj3240455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  178. Moriya S., Kazlauskas A., Akimoto K., Hirai S., Mizuno K., Takenawa T., Fukui Y., Watanabe Y., Ozaki S., Ohno S. Platelet-derived growth factor activates protein kinase C epsilon through redundant and independent signaling pathways involving phospholipase C gamma or phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):151–155. doi: 10.1073/pnas.93.1.151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  179. Mothe I., Delahaye L., Filloux C., Pons S., White M. F., Van Obberghen E. Interaction of wild type and dominant-negative p55PIK regulatory subunit of phosphatidylinositol 3-kinase with insulin-like growth factor-1 signaling proteins. Mol Endocrinol. 1997 Dec;11(13):1911–1923. doi: 10.1210/mend.11.13.0029. [DOI] [PubMed] [Google Scholar]
  180. Mothe I., Van Obberghen E. Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J Biol Chem. 1996 May 10;271(19):11222–11227. doi: 10.1074/jbc.271.19.11222. [DOI] [PubMed] [Google Scholar]
  181. Moule S. K., Edgell N. J., Welsh G. I., Diggle T. A., Foulstone E. J., Heesom K. J., Proud C. G., Denton R. M. Multiple signalling pathways involved in the stimulation of fatty acid and glycogen synthesis by insulin in rat epididymal fat cells. Biochem J. 1995 Oct 15;311(Pt 2):595–601. doi: 10.1042/bj3110595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  182. Moxham C. M., Tabrizchi A., Davis R. J., Malbon C. C. Jun N-terminal kinase mediates activation of skeletal muscle glycogen synthase by insulin in vivo. J Biol Chem. 1996 Nov 29;271(48):30765–30773. doi: 10.1074/jbc.271.48.30765. [DOI] [PubMed] [Google Scholar]
  183. Murata K., Wu J., Brautigan D. L. B cell receptor-associated protein alpha4 displays rapamycin-sensitive binding directly to the catalytic subunit of protein phosphatase 2A. Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):10624–10629. doi: 10.1073/pnas.94.20.10624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  184. Muslin A. J., Tanner J. W., Allen P. M., Shaw A. S. Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine. Cell. 1996 Mar 22;84(6):889–897. doi: 10.1016/s0092-8674(00)81067-3. [DOI] [PubMed] [Google Scholar]
  185. Myers M. G., Jr, Backer J. M., Sun X. J., Shoelson S., Hu P., Schlessinger J., Yoakim M., Schaffhausen B., White M. F. IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10350–10354. doi: 10.1073/pnas.89.21.10350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  186. Myers M. G., Jr, Zhang Y., Aldaz G. A., Grammer T., Glasheen E. M., Yenush L., Wang L. M., Sun X. J., Blenis J., Pierce J. H. YMXM motifs and signaling by an insulin receptor substrate 1 molecule without tyrosine phosphorylation sites. Mol Cell Biol. 1996 Aug;16(8):4147–4155. doi: 10.1128/mcb.16.8.4147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  187. Nakanishi H., Brewer K. A., Exton J. H. Activation of the zeta isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 1993 Jan 5;268(1):13–16. [PubMed] [Google Scholar]
  188. Nakanishi S., Catt K. J., Balla T. A wortmannin-sensitive phosphatidylinositol 4-kinase that regulates hormone-sensitive pools of inositolphospholipids. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5317–5321. doi: 10.1073/pnas.92.12.5317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  189. Navé B. T., Haigh R. J., Hayward A. C., Siddle K., Shepherd P. R. Compartment-specific regulation of phosphoinositide 3-kinase by platelet-derived growth factor and insulin in 3T3-L1 adipocytes. Biochem J. 1996 Aug 15;318(Pt 1):55–60. doi: 10.1042/bj3180055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  190. Navé B. T., Siddle K., Shepherd P. R. Phorbol esters stimulate phosphatidylinositol 3,4,5-trisphosphate production in 3T3-L1 adipocytes: implications for stimulation of glucose transport. Biochem J. 1996 Aug 15;318(Pt 1):203–205. doi: 10.1042/bj3180203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  191. Nobes C. D., Hawkins P., Stephens L., Hall A. Activation of the small GTP-binding proteins rho and rac by growth factor receptors. J Cell Sci. 1995 Jan;108(Pt 1):225–233. doi: 10.1242/jcs.108.1.225. [DOI] [PubMed] [Google Scholar]
  192. Oka Y., Mottola C., Oppenheimer C. L., Czech M. P. Insulin activates the appearance of insulin-like growth factor II receptors on the adipocyte cell surface. Proc Natl Acad Sci U S A. 1984 Jul;81(13):4028–4032. doi: 10.1073/pnas.81.13.4028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  193. Okada T., Kawano Y., Sakakibara T., Hazeki O., Ui M. Essential role of phosphatidylinositol 3-kinase in insulin-induced glucose transport and antilipolysis in rat adipocytes. Studies with a selective inhibitor wortmannin. J Biol Chem. 1994 Feb 4;269(5):3568–3573. [PubMed] [Google Scholar]
  194. Osawa H., Sutherland C., Robey R. B., Printz R. L., Granner D. K. Analysis of the signaling pathway involved in the regulation of hexokinase II gene transcription by insulin. J Biol Chem. 1996 Jul 12;271(28):16690–16694. doi: 10.1074/jbc.271.28.16690. [DOI] [PubMed] [Google Scholar]
  195. Otsu M., Hiles I., Gout I., Fry M. J., Ruiz-Larrea F., Panayotou G., Thompson A., Dhand R., Hsuan J., Totty N. Characterization of two 85 kd proteins that associate with receptor tyrosine kinases, middle-T/pp60c-src complexes, and PI3-kinase. Cell. 1991 Apr 5;65(1):91–104. doi: 10.1016/0092-8674(91)90411-q. [DOI] [PubMed] [Google Scholar]
  196. Ottinger E. A., Botfield M. C., Shoelson S. E. Tandem SH2 domains confer high specificity in tyrosine kinase signaling. J Biol Chem. 1998 Jan 9;273(2):729–735. doi: 10.1074/jbc.273.2.729. [DOI] [PubMed] [Google Scholar]
  197. Palmer R. H., Dekker L. V., Woscholski R., Le Good J. A., Gigg R., Parker P. J. Activation of PRK1 by phosphatidylinositol 4,5-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate. A comparison with protein kinase C isotypes. J Biol Chem. 1995 Sep 22;270(38):22412–22416. doi: 10.1074/jbc.270.38.22412. [DOI] [PubMed] [Google Scholar]
  198. Panayotou G., Gish G., End P., Truong O., Gout I., Dhand R., Fry M. J., Hiles I., Pawson T., Waterfield M. D. Interactions between SH2 domains and tyrosine-phosphorylated platelet-derived growth factor beta-receptor sequences: analysis of kinetic parameters by a novel biosensor-based approach. Mol Cell Biol. 1993 Jun;13(6):3567–3576. doi: 10.1128/mcb.13.6.3567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  199. Pawson T., Gish G. D. SH2 and SH3 domains: from structure to function. Cell. 1992 Oct 30;71(3):359–362. doi: 10.1016/0092-8674(92)90504-6. [DOI] [PubMed] [Google Scholar]
  200. Pentyala S. N., Benjamin W. B. Effect of oxaloacetate and phosphorylation on ATP-citrate lyase activity. Biochemistry. 1995 Sep 5;34(35):10961–10969. doi: 10.1021/bi00035a001. [DOI] [PubMed] [Google Scholar]
  201. Pesesse X., Deleu S., De Smedt F., Drayer L., Erneux C. Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP. Biochem Biophys Res Commun. 1997 Oct 29;239(3):697–700. doi: 10.1006/bbrc.1997.7538. [DOI] [PubMed] [Google Scholar]
  202. Petritsch C., Woscholski R., Edelmann H. M., Parker P. J., Ballou L. M. Selective inhibition of p70 S6 kinase activation by phosphatidylinositol 3-kinase inhibitors. Eur J Biochem. 1995 Jun 1;230(2):431–438. doi: 10.1111/j.1432-1033.1995.0431h.x. [DOI] [PubMed] [Google Scholar]
  203. Phung T. L., Roncone A., Jensen K. L., Sparks C. E., Sparks J. D. Phosphoinositide 3-kinase activity is necessary for insulin-dependent inhibition of apolipoprotein B secretion by rat hepatocytes and localizes to the endoplasmic reticulum. J Biol Chem. 1997 Dec 5;272(49):30693–30702. doi: 10.1074/jbc.272.49.30693. [DOI] [PubMed] [Google Scholar]
  204. Pleiman C. M., Hertz W. M., Cambier J. C. Activation of phosphatidylinositol-3' kinase by Src-family kinase SH3 binding to the p85 subunit. Science. 1994 Mar 18;263(5153):1609–1612. doi: 10.1126/science.8128248. [DOI] [PubMed] [Google Scholar]
  205. Pons S., Asano T., Glasheen E., Miralpeix M., Zhang Y., Fisher T. L., Myers M. G., Jr, Sun X. J., White M. F. The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase. Mol Cell Biol. 1995 Aug;15(8):4453–4465. doi: 10.1128/mcb.15.8.4453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  206. Proud C. G., Denton R. M. Molecular mechanisms for the control of translation by insulin. Biochem J. 1997 Dec 1;328(Pt 2):329–341. doi: 10.1042/bj3280329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  207. Proud C. G. p70 S6 kinase: an enigma with variations. Trends Biochem Sci. 1996 May;21(5):181–185. [PubMed] [Google Scholar]
  208. Pullen N., Dennis P. B., Andjelkovic M., Dufner A., Kozma S. C., Hemmings B. A., Thomas G. Phosphorylation and activation of p70s6k by PDK1. Science. 1998 Jan 30;279(5351):707–710. doi: 10.1126/science.279.5351.707. [DOI] [PubMed] [Google Scholar]
  209. Ragolia L., Cherpalis B., Srinivasan M., Begum N. Role of serine/threonine protein phosphatases in insulin regulation of Na+/K+-ATPase activity in cultured rat skeletal muscle cells. J Biol Chem. 1997 Sep 19;272(38):23653–23658. doi: 10.1074/jbc.272.38.23653. [DOI] [PubMed] [Google Scholar]
  210. Rahn T., Ridderstråle M., Tornqvist H., Manganiello V., Fredrikson G., Belfrage P., Degerman E. Essential role of phosphatidylinositol 3-kinase in insulin-induced activation and phosphorylation of the cGMP-inhibited cAMP phosphodiesterase in rat adipocytes. Studies using the selective inhibitor wortmannin. FEBS Lett. 1994 Aug 22;350(2-3):314–318. doi: 10.1016/0014-5793(94)00797-7. [DOI] [PubMed] [Google Scholar]
  211. Rahn T., Rönnstrand L., Leroy M. J., Wernstedt C., Tornqvist H., Manganiello V. C., Belfrage P., Degerman E. Identification of the site in the cGMP-inhibited phosphodiesterase phosphorylated in adipocytes in response to insulin and isoproterenol. J Biol Chem. 1996 May 10;271(19):11575–11580. doi: 10.1074/jbc.271.19.11575. [DOI] [PubMed] [Google Scholar]
  212. Rameh L. E., Arvidsson A. k., Carraway K. L., 3rd, Couvillon A. D., Rathbun G., Crompton A., VanRenterghem B., Czech M. P., Ravichandran K. S., Burakoff S. J. A comparative analysis of the phosphoinositide binding specificity of pleckstrin homology domains. J Biol Chem. 1997 Aug 29;272(35):22059–22066. doi: 10.1074/jbc.272.35.22059. [DOI] [PubMed] [Google Scholar]
  213. Rameh L. E., Chen C. S., Cantley L. C. Phosphatidylinositol (3,4,5)P3 interacts with SH2 domains and modulates PI 3-kinase association with tyrosine-phosphorylated proteins. Cell. 1995 Dec 1;83(5):821–830. doi: 10.1016/0092-8674(95)90195-7. [DOI] [PubMed] [Google Scholar]
  214. Redpath N. T., Foulstone E. J., Proud C. G. Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway. EMBO J. 1996 May 1;15(9):2291–2297. [PMC free article] [PubMed] [Google Scholar]
  215. Reif K., Nobes C. D., Thomas G., Hall A., Cantrell D. A. Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways. Curr Biol. 1996 Nov 1;6(11):1445–1455. doi: 10.1016/s0960-9822(96)00749-x. [DOI] [PubMed] [Google Scholar]
  216. Rickles R. J., Botfield M. C., Weng Z., Taylor J. A., Green O. M., Brugge J. S., Zoller M. J. Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries. EMBO J. 1994 Dec 1;13(23):5598–5604. doi: 10.1002/j.1460-2075.1994.tb06897.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  217. Ricort J. M., Tanti J. F., Van Obberghen E., Le Marchand-Brustel Y. Different effects of insulin and platelet-derived growth factor on phosphatidylinositol 3-kinase at the subcellular level in 3T3-L1 adipocytes. A possible explanation for their specific effects on glucose transport. Eur J Biochem. 1996 Jul 1;239(1):17–22. doi: 10.1111/j.1432-1033.1996.0017u.x. [DOI] [PubMed] [Google Scholar]
  218. Ridderstråle M., Degerman E., Tornqvist H. Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes. J Biol Chem. 1995 Feb 24;270(8):3471–3474. doi: 10.1074/jbc.270.8.3471. [DOI] [PubMed] [Google Scholar]
  219. Rittenhouse S. E. Phosphoinositide 3-kinase activation and platelet function. Blood. 1996 Dec 15;88(12):4401–4414. [PubMed] [Google Scholar]
  220. Rocchi S., Tartare-Deckert S., Mothe I., Van Obberghen E. Identification by mutation of the tyrosine residues in the insulin receptor substrate-1 affecting association with the tyrosine phosphatase 2C and phosphatidylinositol 3-kinase. Endocrinology. 1995 Dec;136(12):5291–5297. doi: 10.1210/endo.136.12.7588273. [DOI] [PubMed] [Google Scholar]
  221. Roche S., Koegl M., Courtneidge S. A. The phosphatidylinositol 3-kinase alpha is required for DNA synthesis induced by some, but not all, growth factors. Proc Natl Acad Sci U S A. 1994 Sep 13;91(19):9185–9189. doi: 10.1073/pnas.91.19.9185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  222. Rodriguez-Viciana P., Warne P. H., Dhand R., Vanhaesebroeck B., Gout I., Fry M. J., Waterfield M. D., Downward J. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature. 1994 Aug 18;370(6490):527–532. doi: 10.1038/370527a0. [DOI] [PubMed] [Google Scholar]
  223. Rodriguez-Viciana P., Warne P. H., Khwaja A., Marte B. M., Pappin D., Das P., Waterfield M. D., Ridley A., Downward J. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell. 1997 May 2;89(3):457–467. doi: 10.1016/s0092-8674(00)80226-3. [DOI] [PubMed] [Google Scholar]
  224. Rodriguez-Viciana P., Warne P. H., Vanhaesebroeck B., Waterfield M. D., Downward J. Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J. 1996 May 15;15(10):2442–2451. [PMC free article] [PubMed] [Google Scholar]
  225. Rondinone C. M., Wang L. M., Lonnroth P., Wesslau C., Pierce J. H., Smith U. Insulin receptor substrate (IRS) 1 is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4171–4175. doi: 10.1073/pnas.94.8.4171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  226. Rordorf-Nikolic T., Van Horn D. J., Chen D., White M. F., Backer J. M. Regulation of phosphatidylinositol 3'-kinase by tyrosyl phosphoproteins. Full activation requires occupancy of both SH2 domains in the 85-kDa regulatory subunit. J Biol Chem. 1995 Feb 24;270(8):3662–3666. doi: 10.1074/jbc.270.8.3662. [DOI] [PubMed] [Google Scholar]
  227. Ruderman N. B., Kapeller R., White M. F., Cantley L. C. Activation of phosphatidylinositol 3-kinase by insulin. Proc Natl Acad Sci U S A. 1990 Feb;87(4):1411–1415. doi: 10.1073/pnas.87.4.1411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  228. Ruiz-Larrea F., Vicendo P., Yaish P., End P., Panayotou G., Fry M. J., Morgan S. J., Thompson A., Parker P. J., Waterfield M. D. Characterization of the bovine brain cytosolic phosphatidylinositol 3-kinase complex. Biochem J. 1993 Mar 1;290(Pt 2):609–616. doi: 10.1042/bj2900609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  229. Saad M. J., Hartmann L. G., de Carvalho D. S., Galoro C. A., Brenelli S. L., Carvalho C. R. Effect of glucagon on insulin receptor substrate-1 (IRS-1) phosphorylation and association with phosphatidylinositol 3-kinase (PI 3-kinase). FEBS Lett. 1995 Aug 14;370(1-2):131–134. doi: 10.1016/0014-5793(95)00809-n. [DOI] [PubMed] [Google Scholar]
  230. Sakaue H., Hara K., Noguchi T., Matozaki T., Kotani K., Ogawa W., Yonezawa K., Waterfield M. D., Kasuga M. Ras-independent and wortmannin-sensitive activation of glycogen synthase by insulin in Chinese hamster ovary cells. J Biol Chem. 1995 May 12;270(19):11304–11309. doi: 10.1074/jbc.270.19.11304. [DOI] [PubMed] [Google Scholar]
  231. Salim K., Bottomley M. J., Querfurth E., Zvelebil M. J., Gout I., Scaife R., Margolis R. L., Gigg R., Smith C. I., Driscoll P. C. Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J. 1996 Nov 15;15(22):6241–6250. [PMC free article] [PubMed] [Google Scholar]
  232. Schiavo G., Gu Q. M., Prestwich G. D., Söllner T. H., Rothman J. E. Calcium-dependent switching of the specificity of phosphoinositide binding to synaptotagmin. Proc Natl Acad Sci U S A. 1996 Nov 12;93(23):13327–13332. doi: 10.1073/pnas.93.23.13327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  233. Schu P. V., Takegawa K., Fry M. J., Stack J. H., Waterfield M. D., Emr S. D. Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. Science. 1993 Apr 2;260(5104):88–91. doi: 10.1126/science.8385367. [DOI] [PubMed] [Google Scholar]
  234. Scott P. H., Belham C. M., al-Hafidh J., Chilvers E. R., Peacock A. J., Gould G. W., Plevin R. A regulatory role for cAMP in phosphatidylinositol 3-kinase/p70 ribosomal S6 kinase-mediated DNA synthesis in platelet-derived-growth-factor-stimulated bovine airway smooth-muscle cells. Biochem J. 1996 Sep 15;318(Pt 3):965–971. doi: 10.1042/bj3180965. [DOI] [PMC free article] [PubMed] [Google Scholar]
  235. Seely B. L., Reichart D. R., Staubs P. A., Jhun B. H., Hsu D., Maegawa H., Milarski K. L., Saltiel A. R., Olefsky J. M. Localization of the insulin-like growth factor I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activating protein. J Biol Chem. 1995 Aug 11;270(32):19151–19157. doi: 10.1074/jbc.270.32.19151. [DOI] [PubMed] [Google Scholar]
  236. Shepherd P. R., Navé B. T., O'Rahilly S. The role of phosphoinositide 3-kinase in insulin signalling. J Mol Endocrinol. 1996 Dec;17(3):175–184. doi: 10.1677/jme.0.0170175. [DOI] [PubMed] [Google Scholar]
  237. Shepherd P. R., Navé B. T., Rincon J., Nolte L. A., Bevan A. P., Siddle K., Zierath J. R., Wallberg-Henriksson H. Differential regulation of phosphoinositide 3-kinase adapter subunit variants by insulin in human skeletal muscle. J Biol Chem. 1997 Jul 25;272(30):19000–19007. doi: 10.1074/jbc.272.30.19000. [DOI] [PubMed] [Google Scholar]
  238. Shepherd P. R., Navé B. T., Siddle K. Insulin stimulation of glycogen synthesis and glycogen synthase activity is blocked by wortmannin and rapamycin in 3T3-L1 adipocytes: evidence for the involvement of phosphoinositide 3-kinase and p70 ribosomal protein-S6 kinase. Biochem J. 1995 Jan 1;305(Pt 1):25–28. doi: 10.1042/bj3050025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  239. Shepherd P. R., Reaves B. J., Davidson H. W. Phosphoinositide 3-kinases and membrane traffic. Trends Cell Biol. 1996 Mar;6(3):92–97. doi: 10.1016/0962-8924(96)80998-6. [DOI] [PubMed] [Google Scholar]
  240. Shepherd P. R., Soos M. A., Siddle K. Inhibitors of phosphoinositide 3-kinase block exocytosis but not endocytosis of transferrin receptors in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 1995 Jun 15;211(2):535–539. doi: 10.1006/bbrc.1995.1846. [DOI] [PubMed] [Google Scholar]
  241. Shibasaki F., Fukami K., Fukui Y., Takenawa T. Phosphatidylinositol 3-kinase binds to alpha-actinin through the p85 subunit. Biochem J. 1994 Sep 1;302(Pt 2):551–557. doi: 10.1042/bj3020551. [DOI] [PMC free article] [PubMed] [Google Scholar]
  242. Shibata H., Omata W., Kojima I. Insulin stimulates guanine nucleotide exchange on Rab4 via a wortmannin-sensitive signaling pathway in rat adipocytes. J Biol Chem. 1997 Jun 6;272(23):14542–14546. doi: 10.1074/jbc.272.23.14542. [DOI] [PubMed] [Google Scholar]
  243. Shoelson S. E., Chatterjee S., Chaudhuri M., White M. F. YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2027–2031. doi: 10.1073/pnas.89.6.2027. [DOI] [PMC free article] [PubMed] [Google Scholar]
  244. Sjölander A., Yamamoto K., Huber B. E., Lapetina E. G. Association of p21ras with phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A. 1991 Sep 15;88(18):7908–7912. doi: 10.1073/pnas.88.18.7908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  245. Skolnik E. Y., Margolis B., Mohammadi M., Lowenstein E., Fischer R., Drepps A., Ullrich A., Schlessinger J. Cloning of PI3 kinase-associated p85 utilizing a novel method for expression/cloning of target proteins for receptor tyrosine kinases. Cell. 1991 Apr 5;65(1):83–90. doi: 10.1016/0092-8674(91)90410-z. [DOI] [PubMed] [Google Scholar]
  246. Smith-Hall J., Pons S., Patti M. E., Burks D. J., Yenush L., Sun X. J., Kahn C. R., White M. F. The 60 kDa insulin receptor substrate functions like an IRS protein (pp60IRS3) in adipose cells. Biochemistry. 1997 Jul 8;36(27):8304–8310. doi: 10.1021/bi9630974. [DOI] [PubMed] [Google Scholar]
  247. Songyang Z., Carraway K. L., 3rd, Eck M. J., Harrison S. C., Feldman R. A., Mohammadi M., Schlessinger J., Hubbard S. R., Smith D. P., Eng C. Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature. 1995 Feb 9;373(6514):536–539. doi: 10.1038/373536a0. [DOI] [PubMed] [Google Scholar]
  248. Songyang Z., Shoelson S. E., Chaudhuri M., Gish G., Pawson T., Haser W. G., King F., Roberts T., Ratnofsky S., Lechleider R. J. SH2 domains recognize specific phosphopeptide sequences. Cell. 1993 Mar 12;72(5):767–778. doi: 10.1016/0092-8674(93)90404-e. [DOI] [PubMed] [Google Scholar]
  249. Standaert M. L., Galloway L., Karnam P., Bandyopadhyay G., Moscat J., Farese R. V. Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport. J Biol Chem. 1997 Nov 28;272(48):30075–30082. doi: 10.1074/jbc.272.48.30075. [DOI] [PubMed] [Google Scholar]
  250. Staubs P. A., Reichart D. R., Saltiel A. R., Milarski K. L., Maegawa H., Berhanu P., Olefsky J. M., Seely B. L. Localization of the insulin receptor binding sites for the SH2 domain proteins p85, Syp, and GAP. J Biol Chem. 1994 Nov 4;269(44):27186–27192. [PubMed] [Google Scholar]
  251. Stephens L. R., Eguinoa A., Erdjument-Bromage H., Lui M., Cooke F., Coadwell J., Smrcka A. S., Thelen M., Cadwallader K., Tempst P. The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell. 1997 Apr 4;89(1):105–114. doi: 10.1016/s0092-8674(00)80187-7. [DOI] [PubMed] [Google Scholar]
  252. Stephens L. R., Hughes K. T., Irvine R. F. Pathway of phosphatidylinositol(3,4,5)-trisphosphate synthesis in activated neutrophils. Nature. 1991 May 2;351(6321):33–39. doi: 10.1038/351033a0. [DOI] [PubMed] [Google Scholar]
  253. Stephens L. R., Jackson T. R., Hawkins P. T. Agonist-stimulated synthesis of phosphatidylinositol(3,4,5)-trisphosphate: a new intracellular signalling system? Biochim Biophys Acta. 1993 Oct 7;1179(1):27–75. doi: 10.1016/0167-4889(93)90072-w. [DOI] [PubMed] [Google Scholar]
  254. Stephens L., Anderson K., Stokoe D., Erdjument-Bromage H., Painter G. F., Holmes A. B., Gaffney P. R., Reese C. B., McCormick F., Tempst P. Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B. Science. 1998 Jan 30;279(5351):710–714. doi: 10.1126/science.279.5351.710. [DOI] [PubMed] [Google Scholar]
  255. Stephens L., Eguinoa A., Corey S., Jackson T., Hawkins P. T. Receptor stimulated accumulation of phosphatidylinositol (3,4,5)-trisphosphate by G-protein mediated pathways in human myeloid derived cells. EMBO J. 1993 Jun;12(6):2265–2273. doi: 10.1002/j.1460-2075.1993.tb05880.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  256. Stokoe D., Stephens L. R., Copeland T., Gaffney P. R., Reese C. B., Painter G. F., Holmes A. B., McCormick F., Hawkins P. T. Dual role of phosphatidylinositol-3,4,5-trisphosphate in the activation of protein kinase B. Science. 1997 Jul 25;277(5325):567–570. doi: 10.1126/science.277.5325.567. [DOI] [PubMed] [Google Scholar]
  257. Stoyanov B., Volinia S., Hanck T., Rubio I., Loubtchenkov M., Malek D., Stoyanova S., Vanhaesebroeck B., Dhand R., Nürnberg B. Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science. 1995 Aug 4;269(5224):690–693. doi: 10.1126/science.7624799. [DOI] [PubMed] [Google Scholar]
  258. Stoyanova S., Bulgarelli-Leva G., Kirsch C., Hanck T., Klinger R., Wetzker R., Wymann M. P. Lipid kinase and protein kinase activities of G-protein-coupled phosphoinositide 3-kinase gamma: structure-activity analysis and interactions with wortmannin. Biochem J. 1997 Jun 1;324(Pt 2):489–495. doi: 10.1042/bj3240489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  259. Stricker R., Hülser E., Fischer J., Jarchau T., Walter U., Lottspeich F., Reiser G. cDNA cloning of porcine p42IP4, a membrane-associated and cytosolic 42 kDa inositol(1,3,4,5)tetrakisphosphate receptor from pig brain with similarly high affinity for phosphatidylinositol (3,4,5)P3. FEBS Lett. 1997 Mar 24;405(2):229–236. doi: 10.1016/s0014-5793(97)00188-9. [DOI] [PubMed] [Google Scholar]
  260. Suga J., Yoshimasa Y., Yamada K., Yamamoto Y., Inoue G., Okamoto M., Hayashi T., Shigemoto M., Kosaki A., Kuzuya H. Differential activation of mitogen-activated protein kinase by insulin and epidermal growth factor in 3T3-L1 adipocytes: a possible involvement of PI3-kinase in the activation of the MAP kinase by insulin. Diabetes. 1997 May;46(5):735–741. doi: 10.2337/diab.46.5.735. [DOI] [PubMed] [Google Scholar]
  261. Sun X. J., Crimmins D. L., Myers M. G., Jr, Miralpeix M., White M. F. Pleiotropic insulin signals are engaged by multisite phosphorylation of IRS-1. Mol Cell Biol. 1993 Dec;13(12):7418–7428. doi: 10.1128/mcb.13.12.7418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  262. Sun X. J., Miralpeix M., Myers M. G., Jr, Glasheen E. M., Backer J. M., Kahn C. R., White M. F. Expression and function of IRS-1 in insulin signal transmission. J Biol Chem. 1992 Nov 5;267(31):22662–22672. [PubMed] [Google Scholar]
  263. Sun X. J., Rothenberg P., Kahn C. R., Backer J. M., Araki E., Wilden P. A., Cahill D. A., Goldstein B. J., White M. F. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature. 1991 Jul 4;352(6330):73–77. doi: 10.1038/352073a0. [DOI] [PubMed] [Google Scholar]
  264. Sun X. J., Wang L. M., Zhang Y., Yenush L., Myers M. G., Jr, Glasheen E., Lane W. S., Pierce J. H., White M. F. Role of IRS-2 in insulin and cytokine signalling. Nature. 1995 Sep 14;377(6545):173–177. doi: 10.1038/377173a0. [DOI] [PubMed] [Google Scholar]
  265. Sutherland C., Cohen P. The alpha-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro. FEBS Lett. 1994 Jan 24;338(1):37–42. doi: 10.1016/0014-5793(94)80112-6. [DOI] [PubMed] [Google Scholar]
  266. Sutherland C., O'Brien R. M., Granner D. K. Phosphatidylinositol 3-kinase, but not p70/p85 ribosomal S6 protein kinase, is required for the regulation of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by insulin. Dissociation of signaling pathways for insulin and phorbol ester regulation of PEPCK gene expression. J Biol Chem. 1995 Jun 30;270(26):15501–15506. doi: 10.1074/jbc.270.26.15501. [DOI] [PubMed] [Google Scholar]
  267. Sánchez-Margalet V., Goldfine I. D., Truitt K., Imboden J., Sung C. K. Role of p85 subunit of phosphatidylinositol-3-kinase as an adaptor molecule linking the insulin receptor to insulin receptor substrate 1. Mol Endocrinol. 1995 Apr;9(4):435–442. doi: 10.1210/mend.9.4.7659087. [DOI] [PubMed] [Google Scholar]
  268. Tamemoto H., Kadowaki T., Tobe K., Yagi T., Sakura H., Hayakawa T., Terauchi Y., Ueki K., Kaburagi Y., Satoh S. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 1994 Nov 10;372(6502):182–186. doi: 10.1038/372182a0. [DOI] [PubMed] [Google Scholar]
  269. Tanaka C., Nishizuka Y. The protein kinase C family for neuronal signaling. Annu Rev Neurosci. 1994;17:551–567. doi: 10.1146/annurev.ne.17.030194.003003. [DOI] [PubMed] [Google Scholar]
  270. Tanaka K., Imajoh-Ohmi S., Sawada T., Shirai R., Hashimoto Y., Iwasaki S., Kaibuchi K., Kanaho Y., Shirai T., Terada Y. A target of phosphatidylinositol 3,4,5-trisphosphate with a zinc finger motif similar to that of the ADP-ribosylation-factor GTPase-activating protein and two pleckstrin homology domains. Eur J Biochem. 1997 Apr 15;245(2):512–519. doi: 10.1111/j.1432-1033.1997.00512.x. [DOI] [PubMed] [Google Scholar]
  271. Tanasijevic M. J., Myers M. G., Jr, Thoma R. S., Crimmins D. L., White M. F., Sacks D. B. Phosphorylation of the insulin receptor substrate IRS-1 by casein kinase II. J Biol Chem. 1993 Aug 25;268(24):18157–18166. [PubMed] [Google Scholar]
  272. Tanti J. F., Grillo S., Grémeaux T., Coffer P. J., Van Obberghen E., Le Marchand-Brustel Y. Potential role of protein kinase B in glucose transporter 4 translocation in adipocytes. Endocrinology. 1997 May;138(5):2005–2010. doi: 10.1210/endo.138.5.5136. [DOI] [PubMed] [Google Scholar]
  273. Tanti J. F., Grémeaux T., Grillo S., Calleja V., Klippel A., Williams L. T., Van Obberghen E., Le Marchand-Brustel Y. Overexpression of a constitutively active form of phosphatidylinositol 3-kinase is sufficient to promote Glut 4 translocation in adipocytes. J Biol Chem. 1996 Oct 11;271(41):25227–25232. doi: 10.1074/jbc.271.41.25227. [DOI] [PubMed] [Google Scholar]
  274. Tanti J. F., Grémeaux T., Van Obberghen E., Le Marchand-Brustel Y. Insulin receptor substrate 1 is phosphorylated by the serine kinase activity of phosphatidylinositol 3-kinase. Biochem J. 1994 Nov 15;304(Pt 1):17–21. doi: 10.1042/bj3040017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  275. Tanti J. F., Grémeaux T., van Obberghen E., Le Marchand-Brustel Y. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. J Biol Chem. 1994 Feb 25;269(8):6051–6057. [PubMed] [Google Scholar]
  276. Toker A., Cantley L. C. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature. 1997 Jun 12;387(6634):673–676. doi: 10.1038/42648. [DOI] [PubMed] [Google Scholar]
  277. Toker A., Meyer M., Reddy K. K., Falck J. R., Aneja R., Aneja S., Parra A., Burns D. J., Ballas L. M., Cantley L. C. Activation of protein kinase C family members by the novel polyphosphoinositides PtdIns-3,4-P2 and PtdIns-3,4,5-P3. J Biol Chem. 1994 Dec 23;269(51):32358–32367. [PubMed] [Google Scholar]
  278. Tomiyama K., Nakata H., Sasa H., Arimura S., Nishio E., Watanabe Y. Wortmannin, a specific phosphatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells. Biochem Biophys Res Commun. 1995 Jul 6;212(1):263–269. doi: 10.1006/bbrc.1995.1965. [DOI] [PubMed] [Google Scholar]
  279. Traynor-Kaplan A. E., Harris A. L., Thompson B. L., Taylor P., Sklar L. A. An inositol tetrakisphosphate-containing phospholipid in activated neutrophils. Nature. 1988 Jul 28;334(6180):353–356. doi: 10.1038/334353a0. [DOI] [PubMed] [Google Scholar]
  280. Tsakiridis T., McDowell H. E., Walker T., Downes C. P., Hundal H. S., Vranic M., Klip A. Multiple roles of phosphatidylinositol 3-kinase in regulation of glucose transport, amino acid transport, and glucose transporters in L6 skeletal muscle cells. Endocrinology. 1995 Oct;136(10):4315–4322. doi: 10.1210/endo.136.10.7664650. [DOI] [PubMed] [Google Scholar]
  281. Ueki K., Yamamoto-Honda R., Kaburagi Y., Yamauchi T., Tobe K., Burgering B. M., Coffer P. J., Komuro I., Akanuma Y., Yazaki Y. Potential role of protein kinase B in insulin-induced glucose transport, glycogen synthesis, and protein synthesis. J Biol Chem. 1998 Feb 27;273(9):5315–5322. doi: 10.1074/jbc.273.9.5315. [DOI] [PubMed] [Google Scholar]
  282. Ui M., Okada T., Hazeki K., Hazeki O. Wortmannin as a unique probe for an intracellular signalling protein, phosphoinositide 3-kinase. Trends Biochem Sci. 1995 Aug;20(8):303–307. doi: 10.1016/s0968-0004(00)89056-8. [DOI] [PubMed] [Google Scholar]
  283. Valius M., Kazlauskas A. Phospholipase C-gamma 1 and phosphatidylinositol 3 kinase are the downstream mediators of the PDGF receptor's mitogenic signal. Cell. 1993 Apr 23;73(2):321–334. doi: 10.1016/0092-8674(93)90232-f. [DOI] [PubMed] [Google Scholar]
  284. Van Horn D. J., Myers M. G., Jr, Backer J. M. Direct activation of the phosphatidylinositol 3'-kinase by the insulin receptor. J Biol Chem. 1994 Jan 7;269(1):29–32. [PubMed] [Google Scholar]
  285. Vanhaesebroeck B., Leevers S. J., Panayotou G., Waterfield M. D. Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem Sci. 1997 Jul;22(7):267–272. doi: 10.1016/s0968-0004(97)01061-x. [DOI] [PubMed] [Google Scholar]
  286. Vanhaesebroeck B., Welham M. J., Kotani K., Stein R., Warne P. H., Zvelebil M. J., Higashi K., Volinia S., Downward J., Waterfield M. D. P110delta, a novel phosphoinositide 3-kinase in leukocytes. Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4330–4335. doi: 10.1073/pnas.94.9.4330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  287. Velloso L. A., Folli F., Sun X. J., White M. F., Saad M. J., Kahn C. R. Cross-talk between the insulin and angiotensin signaling systems. Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12490–12495. doi: 10.1073/pnas.93.22.12490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  288. Venkateswarlu K., Oatey P. B., Tavaré J. M., Cullen P. J. Insulin-dependent translocation of ARNO to the plasma membrane of adipocytes requires phosphatidylinositol 3-kinase. Curr Biol. 1998 Apr 9;8(8):463–466. doi: 10.1016/s0960-9822(98)70181-2. [DOI] [PubMed] [Google Scholar]
  289. Virbasius J. V., Guilherme A., Czech M. P. Mouse p170 is a novel phosphatidylinositol 3-kinase containing a C2 domain. J Biol Chem. 1996 Jun 7;271(23):13304–13307. doi: 10.1074/jbc.271.23.13304. [DOI] [PubMed] [Google Scholar]
  290. Vlahos C. J., Matter W. F., Hui K. Y., Brown R. F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem. 1994 Feb 18;269(7):5241–5248. [PubMed] [Google Scholar]
  291. Volinia S., Dhand R., Vanhaesebroeck B., MacDougall L. K., Stein R., Zvelebil M. J., Domin J., Panaretou C., Waterfield M. D. A human phosphatidylinositol 3-kinase complex related to the yeast Vps34p-Vps15p protein sorting system. EMBO J. 1995 Jul 17;14(14):3339–3348. doi: 10.1002/j.1460-2075.1995.tb07340.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  292. Voliovitch H., Schindler D. G., Hadari Y. R., Taylor S. I., Accili D., Zick Y. Tyrosine phosphorylation of insulin receptor substrate-1 in vivo depends upon the presence of its pleckstrin homology region. J Biol Chem. 1995 Jul 28;270(30):18083–18087. doi: 10.1074/jbc.270.30.18083. [DOI] [PubMed] [Google Scholar]
  293. Wagle A., Jivraj S., Garlock G. L., Stapleton S. R. Insulin regulation of glucose-6-phosphate dehydrogenase gene expression is rapamycin-sensitive and requires phosphatidylinositol 3-kinase. J Biol Chem. 1998 Jun 12;273(24):14968–14974. doi: 10.1074/jbc.273.24.14968. [DOI] [PubMed] [Google Scholar]
  294. Walker K. S., Deak M., Paterson A., Hudson K., Cohen P., Alessi D. R. Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha. Biochem J. 1998 Apr 1;331(Pt 1):299–308. doi: 10.1042/bj3310299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  295. Wang J., Auger K. R., Jarvis L., Shi Y., Roberts T. M. Direct association of Grb2 with the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem. 1995 May 26;270(21):12774–12780. doi: 10.1074/jbc.270.21.12774. [DOI] [PubMed] [Google Scholar]
  296. Wang L. M., Michieli P., Lie W. R., Liu F., Lee C. C., Minty A., Sun X. J., Levine A., White M. F., Pierce J. H. The insulin receptor substrate-1-related 4PS substrate but not the interleukin-2R gamma chain is involved in interleukin-13-mediated signal transduction. Blood. 1995 Dec 1;86(11):4218–4227. [PubMed] [Google Scholar]
  297. Welch H., Eguinoa A., Stephens L. R., Hawkins P. T. Protein kinase B and rac are activated in parallel within a phosphatidylinositide 3OH-kinase-controlled signaling pathway. J Biol Chem. 1998 May 1;273(18):11248–11256. doi: 10.1074/jbc.273.18.11248. [DOI] [PubMed] [Google Scholar]
  298. Welsh G. I., Foulstone E. J., Young S. W., Tavaré J. M., Proud C. G. Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase. Biochem J. 1994 Oct 1;303(Pt 1):15–20. doi: 10.1042/bj3030015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  299. Welsh G. I., Proud C. G. Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem J. 1993 Sep 15;294(Pt 3):625–629. doi: 10.1042/bj2940625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  300. Welsh G. I., Stokes C. M., Wang X., Sakaue H., Ogawa W., Kasuga M., Proud C. G. Activation of translation initiation factor eIF2B by insulin requires phosphatidyl inositol 3-kinase. FEBS Lett. 1997 Jun 30;410(2-3):418–422. doi: 10.1016/s0014-5793(97)00579-6. [DOI] [PubMed] [Google Scholar]
  301. Weng Q. P., Andrabi K., Klippel A., Kozlowski M. T., Williams L. T., Avruch J. Phosphatidylinositol 3-kinase signals activation of p70 S6 kinase in situ through site-specific p70 phosphorylation. Proc Natl Acad Sci U S A. 1995 Jun 6;92(12):5744–5748. doi: 10.1073/pnas.92.12.5744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  302. Wennström S., Hawkins P., Cooke F., Hara K., Yonezawa K., Kasuga M., Jackson T., Claesson-Welsh L., Stephens L. Activation of phosphoinositide 3-kinase is required for PDGF-stimulated membrane ruffling. Curr Biol. 1994 May 1;4(5):385–393. doi: 10.1016/s0960-9822(00)00087-7. [DOI] [PubMed] [Google Scholar]
  303. Whitman M., Downes C. P., Keeler M., Keller T., Cantley L. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature. 1988 Apr 14;332(6165):644–646. doi: 10.1038/332644a0. [DOI] [PubMed] [Google Scholar]
  304. Wiese R. J., Mastick C. C., Lazar D. F., Saltiel A. R. Activation of mitogen-activated protein kinase and phosphatidylinositol 3'-kinase is not sufficient for the hormonal stimulation of glucose uptake, lipogenesis, or glycogen synthesis in 3T3-L1 adipocytes. J Biol Chem. 1995 Feb 17;270(7):3442–3446. doi: 10.1074/jbc.270.7.3442. [DOI] [PubMed] [Google Scholar]
  305. Wijkander J., Landström T. R., Manganiello V., Belfrage P., Degerman E. Insulin-induced phosphorylation and activation of phosphodiesterase 3B in rat adipocytes: possible role for protein kinase B but not mitogen-activated protein kinase or p70 S6 kinase. Endocrinology. 1998 Jan;139(1):219–227. doi: 10.1210/endo.139.1.5693. [DOI] [PubMed] [Google Scholar]
  306. Withers D. J., Gutierrez J. S., Towery H., Burks D. J., Ren J. M., Previs S., Zhang Y., Bernal D., Pons S., Shulman G. I. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 1998 Feb 26;391(6670):900–904. doi: 10.1038/36116. [DOI] [PubMed] [Google Scholar]
  307. Withers D. J., Ouwens D. M., Nave B. T., van der Zon G. C., Alarcon C. M., Cardenas M. E., Heitman J., Maassen J. A., Shepherd P. R. Expression, enzyme activity, and subcellular localization of mammalian target of rapamycin in insulin-responsive cells. Biochem Biophys Res Commun. 1997 Dec 29;241(3):704–709. doi: 10.1006/bbrc.1997.7878. [DOI] [PubMed] [Google Scholar]
  308. Wolf G., Trüb T., Ottinger E., Groninga L., Lynch A., White M. F., Miyazaki M., Lee J., Shoelson S. E. PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities. J Biol Chem. 1995 Nov 17;270(46):27407–27410. doi: 10.1074/jbc.270.46.27407. [DOI] [PubMed] [Google Scholar]
  309. Woscholski R., Parker P. J. Inositol lipid 5-phosphatases--traffic signals and signal traffic. Trends Biochem Sci. 1997 Nov;22(11):427–431. doi: 10.1016/s0968-0004(97)01120-1. [DOI] [PubMed] [Google Scholar]
  310. Yamamoto-Honda R., Honda Z., Ueki K., Tobe K., Kaburagi Y., Takahashi Y., Tamemoto H., Suzuki T., Itoh K., Akanuma Y. Mutant of insulin receptor substrate-1 incapable of activating phosphatidylinositol 3-kinase did not mediate insulin-stimulated maturation of Xenopus laevis oocytes. J Biol Chem. 1996 Nov 8;271(45):28677–28681. doi: 10.1074/jbc.271.45.28677. [DOI] [PubMed] [Google Scholar]
  311. Yamamoto-Honda R., Tobe K., Kaburagi Y., Ueki K., Asai S., Yachi M., Shirouzu M., Yodoi J., Akanuma Y., Yokoyama S. Upstream mechanisms of glycogen synthase activation by insulin and insulin-like growth factor-I. Glycogen synthase activation is antagonized by wortmannin or LY294002 but not by rapamycin or by inhibiting p21ras. J Biol Chem. 1995 Feb 10;270(6):2729–2734. doi: 10.1074/jbc.270.6.2729. [DOI] [PubMed] [Google Scholar]
  312. Yamamoto K., Altschuler D., Wood E., Horlick K., Jacobs S., Lapetina E. G. Association of phosphorylated insulin-like growth factor-I receptor with the SH2 domains of phosphatidylinositol 3-kinase p85. J Biol Chem. 1992 Jun 5;267(16):11337–11343. [PubMed] [Google Scholar]
  313. Yamauchi K., Holt K., Pessin J. E. Phosphatidylinositol 3-kinase functions upstream of Ras and Raf in mediating insulin stimulation of c-fos transcription. J Biol Chem. 1993 Jul 15;268(20):14597–14600. [PubMed] [Google Scholar]
  314. Yang J., Clarke J. F., Ester C. J., Young P. W., Kasuga M., Holman G. D. Phosphatidylinositol 3-kinase acts at an intracellular membrane site to enhance GLUT4 exocytosis in 3T3-L1 cells. Biochem J. 1996 Jan 1;313(Pt 1):125–131. doi: 10.1042/bj3130125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  315. Yao R., Cooper G. M. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 1995 Mar 31;267(5206):2003–2006. doi: 10.1126/science.7701324. [DOI] [PubMed] [Google Scholar]
  316. Yatomi Y., Hazeki O., Kume S., Ui M. Suppression by wortmannin of platelet responses to stimuli due to inhibition of pleckstrin phosphorylation. Biochem J. 1992 Aug 1;285(Pt 3):745–751. doi: 10.1042/bj2850745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  317. Yeh J. I., Gulve E. A., Rameh L., Birnbaum M. J. The effects of wortmannin on rat skeletal muscle. Dissociation of signaling pathways for insulin- and contraction-activated hexose transport. J Biol Chem. 1995 Feb 3;270(5):2107–2111. doi: 10.1074/jbc.270.5.2107. [DOI] [PubMed] [Google Scholar]
  318. Yeh W. C., Bierer B. E., McKnight S. L. Rapamycin inhibits clonal expansion and adipogenic differentiation of 3T3-L1 cells. Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):11086–11090. doi: 10.1073/pnas.92.24.11086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  319. Yenush L., Makati K. J., Smith-Hall J., Ishibashi O., Myers M. G., Jr, White M. F. The pleckstrin homology domain is the principal link between the insulin receptor and IRS-1. J Biol Chem. 1996 Sep 27;271(39):24300–24306. doi: 10.1074/jbc.271.39.24300. [DOI] [PubMed] [Google Scholar]
  320. Yenush L., White M. F. The IRS-signalling system during insulin and cytokine action. Bioessays. 1997 Jun;19(6):491–500. doi: 10.1002/bies.950190608. [DOI] [PubMed] [Google Scholar]
  321. Yin Y., Terauchi Y., Solomon G. G., Aizawa S., Rangarajan P. N., Yazaki Y., Kadowaki T., Barrett J. C. Involvement of p85 in p53-dependent apoptotic response to oxidative stress. Nature. 1998 Feb 12;391(6668):707–710. doi: 10.1038/35648. [DOI] [PubMed] [Google Scholar]
  322. Yonezawa K., Ueda H., Hara K., Nishida K., Ando A., Chavanieu A., Matsuba H., Shii K., Yokono K., Fukui Y. Insulin-dependent formation of a complex containing an 85-kDa subunit of phosphatidylinositol 3-kinase and tyrosine-phosphorylated insulin receptor substrate 1. J Biol Chem. 1992 Dec 25;267(36):25958–25965. [PubMed] [Google Scholar]
  323. Yonezawa K., Yokono K., Shii K., Ogawa W., Ando A., Hara K., Baba S., Kaburagi Y., Yamamoto-Honda R., Momomura K. In vitro association of phosphatidylinositol 3-kinase activity with the activated insulin receptor tyrosine kinase. J Biol Chem. 1992 Jan 5;267(1):440–446. [PubMed] [Google Scholar]
  324. Yu H., Chen J. K., Feng S., Dalgarno D. C., Brauer A. W., Schreiber S. L. Structural basis for the binding of proline-rich peptides to SH3 domains. Cell. 1994 Mar 11;76(5):933–945. doi: 10.1016/0092-8674(94)90367-0. [DOI] [PubMed] [Google Scholar]
  325. Yuan Z. M., Utsugisawa T., Huang Y., Ishiko T., Nakada S., Kharbanda S., Weichselbaum R., Kufe D. Inhibition of phosphatidylinositol 3-kinase by c-Abl in the genotoxic stress response. J Biol Chem. 1997 Sep 19;272(38):23485–23488. doi: 10.1074/jbc.272.38.23485. [DOI] [PubMed] [Google Scholar]
  326. Zhang-Sun G., Yang C., Viallet J., Feng G., Bergeron J. J., Posner B. I. A 60-kilodalton protein in rat hepatoma cells overexpressing insulin receptor was tyrosine phosphorylated and associated with Syp, phophatidylinositol 3-kinase, and Grb2 in an insulin-dependent manner. Endocrinology. 1996 Jul;137(7):2649–2658. doi: 10.1210/endo.137.7.8770882. [DOI] [PubMed] [Google Scholar]
  327. Zheng Y., Bagrodia S., Cerione R. A. Activation of phosphoinositide 3-kinase activity by Cdc42Hs binding to p85. J Biol Chem. 1994 Jul 22;269(29):18727–18730. [PubMed] [Google Scholar]
  328. van der Kaay J., Batty I. H., Cross D. A., Watt P. W., Downes C. P. A novel, rapid, and highly sensitive mass assay for phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3) and its application to measure insulin-stimulated PtdIns(3,4,5)P3 production in rat skeletal muscle in vivo. J Biol Chem. 1997 Feb 28;272(9):5477–5481. doi: 10.1074/jbc.272.9.5477. [DOI] [PubMed] [Google Scholar]
  329. von Manteuffel S. R., Gingras A. C., Ming X. F., Sonenberg N., Thomas G. 4E-BP1 phosphorylation is mediated by the FRAP-p70s6k pathway and is independent of mitogen-activated protein kinase. Proc Natl Acad Sci U S A. 1996 Apr 30;93(9):4076–4080. doi: 10.1073/pnas.93.9.4076. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES

-